|
|
CTD Chemicals (CC): Cyclohexanes 
(show info)
Biomedical Ontology
Like Gene Ontology (GO), biomedical ontology such as phenotype ontology classifies and organizes gene-mutant/null phenotypic information from the very general at the top to more specific terms in the directed acyclic graph (DAG) by viewing an individual term as a node and its relations to parental terms (allowing for multiple parents) as directed edges. To navigate this hierarchy, we display all parental phenotypic terms to the current phenotypic term of interest ordered by their shortest distances to the current term. Also, only direct children phenotypic terms of the current phenotypic term are listed. Biomedical ontologies we have incorporated are as follows:
- Disease Ontology (DO) Ontology DO semantically integrates disease and medical vocabularies through extensive cross mapping of DO terms to MeSH, ICD, NCI’s thesaurus, SNOMED and OMIM.
- Human Phenotype (HP) Ontology HP captures phenotypic abnormalities that are described in OMIM, along with the corresponding disease-causing genes. It includes three complementary biological concepts: Mode_of_Inheritance (MI), ONset_and_clinical_course (ON), and Phenotypic_Abnormality (PA).
- Mouse Phenotype (MP) Ontology MP describes phenotypes of the mouse after a specific gene is genetically disrupted. Using it, Mouse Genome Informatics (MGI) provides high-coverate gene-level phenotypes for the mouse.
- Worm Phenotype (WP) Ontology WP classifies and organizes phenotype descriptions for C. elegans and other nematodes. Using it, WormBase provides primary resource for phenotype annotations for C. elegans.
- Yeast Phenotype (YP) Ontology Based on YP which is the major contributor to the ‘Ascomycete phenotype ontology’, Saccharomyces Genome Database (SGD) provides single mutant phenotypes for every gene in the yeast genome.
- Fly Phenotype (FP) Ontology FP refers to FlyBase controlled vocabulary. Specifically, a structured controlled vocabulary is used for the annotation of alleles (for their mutagen etc) in FlyBase.
- Fly Anatomy (FA) Ontology FA is a structured controlled vocabulary of the anatomy of Drosophila melanogaster, used for the description of phenotypes and where a gene is expressed.
- Zebrafish Anatomy (ZA) Ontology ZA displays anatomical terms of the zebrafish using standard anatomical nomenclature, together with affected genes.
- Xenopus Anatomy (XA) Ontology XA represents the lineage of tissues and the timing of development for frogs (Xenopus laevis and Xenopus tropicalis). It is used to annotate Xenopus gene expression patterns and mutant and morphant phenotypes.
- Arabidopsis Plant Ontology (AP) Ontology As a major contributor to Plant Ontology which describes plant anatomical and morphological structures (AN) and growth and developmental stages (DE), the Arabidopsis Information Resource (TAIR) provides arabidopsis plant ontology annotations for the model higher plant Arabidopsis thaliana.
- Enzyme Commission (EC) Ontology Each enzyme is allocated a four-digit EC number, the first three digits of which define the reaction catalysed and the fourth of which is a unique identifier (serial number). Each enzyme is also assigned a systematic name that uniquely defines the reaction catalysed.
- UniProtKB KeyWords (KW) Ontology Keywords in UniProtKB are controlled vocabulary, providing a summary of the entry content and are used to index UniProtKB/Swiss-Prot entries based on 10 categories (the category "Technical term" being excluded here). Each keyword is attributed manually to UniProtKB/Swiss-Prot entries and automatically to UniProtKB/TrEMBL entries (according to specific annotation rules).
- CTD Diseases (CD) Ontology CD is MEDIC disease vocabulary that is modified by CTD from the "Diseases" [C] branch of Medical Subject Headings (MeSH), combined with genetic disorders from the Online Mendelian Inheritance in OMIM database.
- CTD Chemicals (CC) Ontology CC is chemical vocabulary that is adapted by CTD from the "Chemicals and Drugs" category and Supplementary Concept Records of Medical Subject Headings (MeSH, a hierarchical vocabulary used to index articles for MEDLINE/PubMed).
Jump to [ Top · Hierarchy · Annotations ]
Root: CC Hierarchy (CTD chemicals from Comparative Toxicogenomics Database)
| Shortest distance to current term (+ for parents, - for children) |
CC term [CC ID] <#Children> |
#Domains (Superfamily|Family) |
#Supra-domain (Single|Duplex|Triple) |
| + + + + + + 6: | Chemicals [MESH:D] <13> |
| + + + + + 5: | Organic Chemicals [MESH:D009930] <621> | (617|829) |
(620|532|254) |
| + + + + 4: | Hydrocarbons [MESH:D006838] <35> | (468|641) |
(485|436|221) |
| + + + 3: | Polycyclic Compounds [MESH:D011083] <191> | (419|579) |
(431|390|204) |
| + + + 3: | Hydrocarbons, Cyclic [MESH:D006844] <11> | (425|591) |
(443|416|217) |
| + + 2: | Macrocyclic Compounds [MESH:D047028] <111> | (186|253) |
(192|153|75) |
| + + 2: | Hydrocarbons, Alicyclic [MESH:D006840] <3> | (114|125) |
(121|74|36) |
| + 1: | Cycloparaffins [MESH:D003516] <36> | (113|125) |
(120|74|36) |
| 0: | Cyclohexanes [MESH:D003510] <320> | (90|101) |
(94|54|24) |
| - 1: | Cyclohexanones [MESH:D003512] <325> | (8|5) |
(8|4|1) |
| - 1: | Cyclohexenes [MESH:D053138] <169> | (58|70) |
(62|34|16) |
| - 1: | Cyclohexanols [MESH:D003511] <136> | (23|27) |
(23|14|5) |
| - 1: | Cyclohexylamines [MESH:D003514] <118> | (1|1) |
(1|0|0) |
| - 1: | Cyclohexanecarboxylic Acids [MESH:D003509] <108> | (16|15) |
(16|9|2) |
| - 1: | Cyclohexane Monoterpenes [MESH:D000081005] <44> | (16|21) |
(17|12|5) |
| - 1: | Ketamine [MESH:D007649] <10> | (1|0) |
(1|0|0) |
| - 1: | Picrotoxin [MESH:D010852] <7> | (2|2) |
(2|1|0) |
| - 1: | Cyclamates [MESH:D003494] <6> | (0|0) |
(0|0|0) |
| - 1: | Dicyclomine [MESH:D004025] <1> | (0|0) |
(0|0|0) |
| - 1: | Tiletamine [MESH:D013992] <1> | (0|0) |
(0|0|0) |
| - 1: | (1,4,2)-cyclohex-5-ene-triol [MESH:C483224] | (0|0) |
(0|0|0) |
| - 1: | (1-(aminomethyl)-3-methylcyclohexyl)acetic acid [MESH:C112420] | (0|0) |
(0|0|0) |
| - 1: | (1R,2R)-N-(2-aminocyclohexyl)-4-nitrobenzenesulfonamide [MESH:C557462] | (0|0) |
(0|0|0) |
| - 1: | (1R,3S)-N-(2-(cyclopeanthylcarbonyl) amino-benzothiazol-6-yl-3-(2-naphthylmethyl) amino)cyclohexanec [MESH:C503070] | (0|0) |
(0|0|0) |
| - 1: | (1r,4r)-4-amino-N-(3,5-bis(4-carbamimidoylphenoxy)phenyl)cyclohexanecarboxamide [MESH:C000600996] | (0|0) |
(0|0|0) |
| - 1: | (2,4,6-trihydroxyphenyl)(3'-mathyl-2'-(3''-methylbut-2''-enyl)-6-phenylcyclohex-3'-enyl)methanone [MESH:C450300] | (0|0) |
(0|0|0) |
| - 1: | (2-(4-tert-butyl-1-(3,4-dichloro-benzyl)-cyclohexyloxy)-ethyl)-dimethyl-amine hydrochloride [MESH:C574352] | (0|0) |
(0|0|0) |
| - 1: | (2RS,3SR,4RS,6SR)-3-benzoyl-4-hydroxy-2,4,6-triphenylcyclohexane-1,1-dicarbonitrile [MESH:C533321] | (0|0) |
(0|0|0) |
| - 1: | (4-((1R, 2S, 3R, 5R)-5-Chloro-2-((S)-3-cyclohexyl-3-hydroxyprop-1-ynyl)-3-hydroxycyclopentyl) butylt [MESH:C518544] | (0|0) |
(0|0|0) |
| - 1: | (E,E,E,E)-2-(9-(2-hydroxyethyl)imino-3,7-dimethyl-1,3,5,7-decatrien-1-yl)- 1,3,3-trimethylcyclohexen [MESH:C479486] | (0|0) |
(0|0|0) |
| - 1: | (N-(cyclohexylmethyl)glycyl)-(N-(1-methylhexyl)glycyl)-(N-(4-methylbenzyl)glycyl)-(N-(2-(3-chlorophe [MESH:C512500] | (0|0) |
(0|0|0) |
| - 1: | (S)-2-cyclohexyl-2-phenylglycolic acid [MESH:C512920] | (0|0) |
(0|0|0) |
| - 1: | 1',2',3',4',4a',5',6',7'-octahydrodispiro(cyclohexane-1,2'-quinazoline-4',1'-cyclohexane)-8'-carbodi [MESH:C544521] | (0|0) |
(0|0|0) |
| - 1: | 1,1'-((1S,3R,4S,6R)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl)diguanidinium sulfate monohydrate [MESH:C543558] | (0|0) |
(0|0|0) |
| - 1: | 1,1,3-tris(3-indolyl)cyclohexane [MESH:C531174] | (0|0) |
(0|0|0) |
| - 1: | 1,1-bis(4-hydroxyphenyl)cyclohexane [MESH:C517113] | (2|2) |
(2|1|0) |
| - 1: | 1,1-diethoxycyclohexane [MESH:C571807] | (0|0) |
(0|0|0) |
| - 1: | 1,1-diphenyl-3,3'-((1R,2R)-cyclohexane-1,2-diylbis(azanediyl))dibut-2-en-1-one [MESH:C000588703] | (0|0) |
(0|0|0) |
| - 1: | 1,2,3,4,5,6-cyclohexanehexacarboxylate [MESH:C532002] | (0|0) |
(0|0|0) |
| - 1: | 1,2,3,4,5,6-hexabromocyclohexane [MESH:C500162] | (0|0) |
(0|0|0) |
| - 1: | 1,2,3,4-tetrafluorocyclohexane [MESH:C562015] | (0|0) |
(0|0|0) |
| - 1: | 1,2,4,5-4-bromo-5-bromomethyl-1-(E)-chlorovinyl-2,5-dichloromethylcyclohexane [MESH:C451679] | (0|0) |
(0|0|0) |
| - 1: | 1,2,4,5-diepoxycyclohexane [MESH:C547262] | (0|0) |
(0|0|0) |
| - 1: | 1,2,4,5-tetraimino-3,6-diketocyclohexane [MESH:C546129] | (0|0) |
(0|0|0) |
| - 1: | 1,2,4-trimethylcyclohexane [MESH:C069243] | (0|0) |
(0|0|0) |
| - 1: | 1,2,4-trivinylcyclohexane [MESH:C000600384] | (0|0) |
(0|0|0) |
| - 1: | 1,2-bis(2-mercaptoacetamido)cyclohexane [MESH:C403499] | (0|0) |
(0|0|0) |
| - 1: | 1,2-cyclohexylimidocarbonate [MESH:C002560] | (0|0) |
(0|0|0) |
| - 1: | 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane [MESH:C517232] | (0|0) |
(0|0|0) |
| - 1: | 1,2-dibromocyclohexane [MESH:C453159] | (0|0) |
(0|0|0) |
| - 1: | 1,2-dichlorocyclohexane [MESH:C021991] | (0|0) |
(0|0|0) |
| - 1: | 1,2-dimethylcyclohexa-2,5-dienecarboxylic acid [MESH:C425123] | (0|0) |
(0|0|0) |
| - 1: | 1,2-dimethylcyclohexane [MESH:C068558] | (0|0) |
(0|0|0) |
| - 1: | 1,3,4-trifluoro-2-phenylcyclohexane [MESH:C000599815] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-cyclohexanetricarboxylate [MESH:C517114] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-trimethylcyclohexane-1,3,5-tricarboxylic acid [MESH:C452447] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-tris((2,3-dihydroxybenzylidene)aminomethyl)cyclohexane [MESH:C538816] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-tris(3-(2-furyl)prop-2-enylideneamino)cyclohexane [MESH:C441819] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-tris(3-(3-hydroxy-2-methyl-4-oxo-4H-pyridin-1-yl)propylcarbamoyl)-1,3,5-trimethylcyclohexane [MESH:C538915] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-tris(4-(3-hydroxy-2-methyl-4-oxo-4H-pyridin-1-yl)butylcarbamoyl)-1,3,5-trimethylcyclohexane [MESH:C538916] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-trithiacyclohexane [MESH:C469819] | (0|0) |
(0|0|0) |
| - 1: | 1,3-bis(isocyanatomethyl)cyclohexane [MESH:C103285] | (0|0) |
(0|0|0) |
| - 1: | 1,3-cyclohexanebis(methylamine) [MESH:C118804] | (0|0) |
(0|0|0) |
| - 1: | 1,3-di-tert-butyl-5-methylcyclohexane [MESH:C056115] | (0|0) |
(0|0|0) |
| - 1: | 1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-((R)-3-cyclo-hexyl-1-phenylpropyl)-1,3-dioxo-2,3-di [MESH:C503118] | (0|0) |
(0|0|0) |
| - 1: | 1,3-dihydroxy-4,5-dicaffeoyloxy cyclohexane carboxylic acid methyl ester [MESH:C426103] | (0|0) |
(0|0|0) |
| - 1: | 1,3-dimethoxy-5-methyl-2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)benzene [MESH:C552735] | (0|0) |
(0|0|0) |
| - 1: | 1,4-cyclohexanedimethanol [MESH:C023353] | (0|0) |
(0|0|0) |
| - 1: | 1,4-dithiacyclohexane 1,1-dioxide [MESH:C516085] | (0|0) |
(0|0|0) |
| - 1: | 1,6-dichlorohexane [MESH:C518164] | (0|0) |
(0|0|0) |
| - 1: | 1-(1-naphthalenethoxy)-2-(3-ketopyrrolidinyl)cyclohexane [MESH:C521967] | (0|0) |
(0|0|0) |
| - 1: | 1-(2,4-dimethyl-3-cyclohexenyl)-2,2-dimethylpropan-1-one [MESH:C000589214] | (0|0) |
(0|0|0) |
| - 1: | 1-(2,6,6-trimethyl-2-cyclohexen-1yl)propan-2-one [MESH:C494863] | (0|0) |
(0|0|0) |
| - 1: | 1-(2-bromophenyl)cyclohexanecarboxamide [MESH:C545466] | (0|0) |
(0|0|0) |
| - 1: | 1-(3,3-dimethylcyclohexyl)ethan-1-one [MESH:C000589155] | (0|0) |
(0|0|0) |
| - 1: | 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one [MESH:C000589212] | (0|0) |
(0|0|0) |
| - 1: | 1-(4'-cyanophenyl)-4-propylcyclohexane [MESH:C000606449] | (0|0) |
(0|0|0) |
| - 1: | 1-(4-hexylcyclohexyl)-4-isothiocyanatobenzene [MESH:C544296] | (0|0) |
(0|0|0) |
| - 1: | 1-amino-2-(3-indolyl)cyclohexane-1-carboxylic acid [MESH:C470339] | (0|0) |
(0|0|0) |
| - 1: | 1-amino-4-phenylcyclohexane-1-carboxylic acid [MESH:C506369] | (0|0) |
(0|0|0) |
| - 1: | 1-chlorocyclohexene oxide [MESH:C039058] | (0|0) |
(0|0|0) |
| - 1: | 1-cyclohexylpyrrolidin-2-one [MESH:C575206] | (0|0) |
(0|0|0) |
| - 1: | 1-ethynylcyclohexene [MESH:C522558] | (0|0) |
(0|0|0) |
| - 1: | 1-phenylcyclohex-1-ene [MESH:C034672] | (0|0) |
(0|0|0) |
| - 1: | 12-(3-cyclo-hexyl-ureido)-dodecanoic acid [MESH:C482226] | (0|0) |
(0|0|0) |
| - 1: | 16,17-cyclohexano-4,5-dihydroprogesterone [MESH:C460860] | (0|0) |
(0|0|0) |
| - 1: | 1R,2R-diaminocyclohexane [MESH:C000595887] | (0|0) |
(0|0|0) |
| - 1: | 2,2,4,4-tetramethyl-6-(1-oxo-3-phenylprop-2-enyl) cyclohexane-1,3,5-trione [MESH:C505177] | (0|0) |
(0|0|0) |
| - 1: | 2,2,4-trimethyl-6-(1-oxo-3-phenylprop-2-enyl)cyclohexane-1,3,5-trione [MESH:C505176] | (0|0) |
(0|0|0) |
| - 1: | 2,2-dicyclohexyl-5-((dimethylamino)methyl)-1,3-oxathiolane methiodide [MESH:C056976] | (0|0) |
(0|0|0) |
| - 1: | 2,3,4,5,6-pentachlorocyclohexene [MESH:C524862] | (0|0) |
(0|0|0) |
| - 1: | 2,4-dihydroxy-2,6-trimethyl-cyclohexaneacetic-lactone [MESH:C468235] | (0|0) |
(0|0|0) |
| - 1: | 2,6,6-trimethylcyclohex-2-ene-1,4-dione [MESH:C428327] | (0|0) |
(0|0|0) |
| - 1: | 2-((2-(1-cyclohexen-1-yl)ethyl)amino)adenosine [MESH:C083894] | (0|0) |
(0|0|0) |
| - 1: | 2-((2-cyclohexylethyl)amino)adenosine [MESH:C070485] | (0|0) |
(0|0|0) |
| - 1: | 2-((cyclohexylmethylimino)-methyl)-naphthalen-1-ol [MESH:C000604633] | (0|0) |
(0|0|0) |
| - 1: | 2-(1-((pyrazin-2-ylformamido)methyl)cyclohexyl)acetic acid [MESH:C587108] | (0|0) |
(0|0|0) |
| - 1: | 2-(1-cyclohexenyl)ethylamine [MESH:C524450] | (0|0) |
(0|0|0) |
| - 1: | 2-(1-phenylcyclohex-1-yl)ethanamine [MESH:C478615] | (0|0) |
(0|0|0) |
| - 1: | 2-(2',2'-dimethyl-6'-methylenecyclohexyl)ethanol [MESH:C121486] | (0|0) |
(0|0|0) |
| - 1: | 2-(2-(2-chloro-3-(2-(3,3-dimethyl-5-sulfo-1-(4-sulfo-butyl)-3H-indol-2-yl)-vinyl)-cyclohex-2-enylide [MESH:C503267] | (0|0) |
(0|0|0) |
| - 1: | 2-(2-decenoylamino)ethyl-2-(cyclohexylethyl)sulfide [MESH:C072658] | (0|0) |
(0|0|0) |
| - 1: | 2-(2-nitro-4-(trifluoromethyl)benzoyl)-4,4,6,6-tetramethylcyclohexane-1,3,5-trione [MESH:C098916] | (0|0) |
(0|0|0) |
| - 1: | 2-(3-hydroxy-3-methylbutyl)-4-cyclohexylidine carboxylic acid [MESH:C095916] | (0|0) |
(0|0|0) |
| - 1: | 2-(3-hydroxy-3-methylbutyl)cyclohexylidene [MESH:C095915] | (0|0) |
(0|0|0) |
| - 1: | 2-(4-(4-methoxyphenylcarbonyloxy)benzylidene)-6-dimethylaminomethyl cyclohexanone hydrochloride [MESH:C554749] | (0|0) |
(0|0|0) |
| - 1: | 2-(4-chlorobutyl)cyclohexanecarbonitrile [MESH:C463240] | (0|0) |
(0|0|0) |
| - 1: | 2-(6-(1-fluoro-cyclohexyl)-pyridin-2-yl)-1H-indole-5-carboxamidine [MESH:C000608578] | (0|0) |
(0|0|0) |
| - 1: | 2-(6-(1-hydroxy-cyclohexyl)-pyridin-2-yl)-1H-indole-5-carboxamidine [MESH:C000608577] | (0|0) |
(0|0|0) |
| - 1: | 2-amino-3-((3,4-difluorophenyl)sulfanylmethyl)-4-hydroxy-bicyclo(3.1.0)hexane-2,6-dicarboxylic acid [MESH:C000620392] | (0|0) |
(0|0|0) |
| - 1: | 2-aza-4,4-spirocyclopropacyclohexadienone [MESH:C478992] | (0|0) |
(0|0|0) |
| - 1: | 2-chloro-1,3-dibenzothiazolinecyclohexene [MESH:C562228] | (0|0) |
(0|0|0) |
| - 1: | 2-chlorocyclohexylthiophthalimide [MESH:C061435] | (0|0) |
(0|0|0) |
| - 1: | 2-cyclohexyl-1,6-heptadien-3-one [MESH:C000589154] | (0|0) |
(0|0|0) |
| - 1: | 2-isothiocyanato-4,5-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide [MESH:C063077] | (0|0) |
(0|0|0) |
| - 1: | 2-isothiocyanato-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide [MESH:C058445] | (0|0) |
(0|0|0) |
| - 1: | 2-methylene-4-(2',2'-dimethyl-6'-methylenecyclohexyl)ethanol [MESH:C121487] | (0|0) |
(0|0|0) |
| - 1: | 2-octanoylcyclohexane-1,3-dione [MESH:C440070] | (0|0) |
(0|0|0) |
| - 1: | 2-oxabicyclo(3.1.0)hexane [MESH:C518114] | (0|0) |
(0|0|0) |
| - 1: | 2-spiro-6'-cyclohexa-2',4'-dien-1'-one [MESH:C507696] | (0|0) |
(0|0|0) |
| - 1: | 2-succinyl-6-hydroxycyclohexa-2,4-diene-1-carboxylic acid [MESH:C087010] | (0|0) |
(0|0|0) |
| - 1: | 2alpha,6alpha-dihydroxy-5-((E)-3'-hydroxy-3'-methyl-1'-butenyl)-6-methyl-4-cyclohexen-3-one [MESH:C493043] | (0|0) |
(0|0|0) |
| - 1: | 3,4-dihydroxy-3,4-dihydrobenzoic acid [MESH:C484573] | (0|0) |
(0|0|0) |
| - 1: | 3,6-dibenzyloxycyclohex-4-ene-1,2-diol [MESH:C435325] | (0|0) |
(0|0|0) |
| - 1: | 3-(1,1-biphenyl)cyclohexane [MESH:C056592] | (0|0) |
(0|0|0) |
| - 1: | 3-(3-((2-(3,4-dimethoxyphenyl)ethyl)-methylamino)cyclohexyl)-7,8-dimethoxy-1,3,4,5-tetrahydrobenzo(d [MESH:C574764] | (0|0) |
(0|0|0) |
| - 1: | 3-(N-(4-chlorophenyl)amino)-5-methyl-2-cyclohexenone [MESH:C495413] | (0|0) |
(0|0|0) |
| - 1: | 3-(tert-butoxycarbonyl)-3-azabicyclo(3.1.0)hexane-2-carboxylic acid [MESH:C586622] | (0|0) |
(0|0|0) |
| - 1: | 3-bromo-1,2-epoxycyclohexane [MESH:C032834] | (0|0) |
(0|0|0) |
| - 1: | 3-isocyanotheonellin [MESH:C480378] | (0|0) |
(0|0|0) |
| - 1: | 3-methyl-2-cyclohexen-1-one [MESH:C473568] | (0|0) |
(0|0|0) |
| - 1: | 3R,7E-9-butoxyl-megastigma-3-ol-3-O-beta-D-glucopyranoside [MESH:C539277] | (0|0) |
(0|0|0) |
| - 1: | 4,4'-cyclohexylidenebisphenol [MESH:C570106] | (1|1) |
(1|0|0) |
| - 1: | 4,4'-diaminodicyclohexylmethane carbonate [MESH:C007295] | (0|0) |
(0|0|0) |
| - 1: | 4,4'-methylene dicyclohexyl diisocyanate [MESH:C404812] | (0|0) |
(0|0|0) |
| - 1: | 4,5-dihydroxy-1,2-dithiacyclohexane [MESH:C520773] | (0|0) |
(0|0|0) |
| - 1: | 4,5-epoxy-2-cyclohexen-1-one [MESH:C511685] | (0|0) |
(0|0|0) |
| - 1: | 4,5-epoxycyclohexene [MESH:C450740] | (0|0) |
(0|0|0) |
| - 1: | 4-(1,2-epoxy-2,6,6-trimethylcyclohexyl)-3-buten-2-one [MESH:C526429] | (0|0) |
(0|0|0) |
| - 1: | 4-(1-phenylcyclohexyl)phenol [MESH:C000592026] | (0|0) |
(0|0|0) |
| - 1: | 4-(3'(R)-hydroxybutyl)-3,5,5, trimethyl-cyclohex-2-en-1-one [MESH:C478848] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-methyl-5-(2',6',6'-trimethyl-1'-cyclohex-1'-yl)pentadienamido)benzoic acid [MESH:C113649] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-methylcyclohexyl)-4-oxobutyric acid [MESH:C116719] | (0|0) |
(0|0|0) |
| - 1: | 4-acetyl-1-methylcyclohexene [MESH:C525009] | (0|0) |
(0|0|0) |
| - 1: | 4-aminocyclohexylalanine [MESH:C521364] | (0|0) |
(0|0|0) |
| - 1: | 4-benzyloxy-2-cyclohexen-1-one [MESH:C429826] | (0|0) |
(0|0|0) |
| - 1: | 4-cyclohexyl-1-ethyl-7-methylpyrido(2,3-d)pyrimidin-2-(1H)-one [MESH:C499820] | (0|0) |
(0|0|0) |
| - 1: | 4-cyclohexylphenyl sulfate [MESH:C018496] | (0|0) |
(0|0|0) |
| - 1: | 4-diphenylacetoxy-1,1-dimethylcyclohexane [MESH:C077361] | (0|0) |
(0|0|0) |
| - 1: | 4-methylcyclohexanemethanol [MESH:C000607184] | (0|0) |
(0|0|0) |
| - 1: | 4-phenyl-2-((3-(tri-fluoromethyl)anilino)methylidene)cyclohexane-1,3-dione [MESH:C572262] | (0|0) |
(0|0|0) |
| - 1: | 4-phenylcyclohexene [MESH:C080904] | (0|0) |
(0|0|0) |
| - 1: | 4-tert-butylcyclohexyl acetate [MESH:C578599] | (0|0) |
(0|0|0) |
| - 1: | 5,5-dimethoxy-1,3-diazacyclohexane [MESH:C503520] | (0|0) |
(0|0|0) |
| - 1: | 5-(2,2-dimethyl-6-methylenecyclohexyl)-3-methyl-2,4-pentadienoic acid [MESH:C525866] | (0|0) |
(0|0|0) |
| - 1: | 5-(6-carboxyhexyl)-1-(3-cyclohexane-3-hydroxypropyl)-5-deoxyhydantoin [MESH:C072612] | (0|0) |
(0|0|0) |
| - 1: | 5-cyclohexyl-5-ethylbarbituric acid [MESH:C000599232] | (0|0) |
(0|0|0) |
| - 1: | 7-(2'-((2''-methyl-1''-oxobutoxy)methyl)-1'-cyclohexyl)-3-hydroxy-5-oxoheptanoic acid [MESH:C058117] | (0|0) |
(0|0|0) |
| - 1: | 7-(2-amino-1-oxo-3-thio-propyl)-8-cyclohexylmethyl-2-phenyl-5,6,7,8-tetrahydro-imidazo-(1,2a)-pyrazi [MESH:C533004] | (0|0) |
(0|0|0) |
| - 1: | 8-phenylmenthol [MESH:C435306] | (0|0) |
(0|0|0) |
| - 1: | 9-O-glucopyranosyl-3-hydroxy-7,8-didehydro-beta-ionol [MESH:C476260] | (0|0) |
(0|0|0) |
| - 1: | AC-186 [MESH:C587712] | (0|0) |
(0|0|0) |
| - 1: | AY 9928 [MESH:C000291] | (0|0) |
(0|0|0) |
| - 1: | BC54 compound [MESH:C000627288] | (0|0) |
(0|0|0) |
| - 1: | CB65 [MESH:C000626985] | (0|0) |
(0|0|0) |
| - 1: | CKD732 [MESH:C487952] | (0|0) |
(0|0|0) |
| - 1: | CPD2 insulin mimetic [MESH:C493136] | (0|0) |
(0|0|0) |
| - 1: | Ciclopirox [MESH:D000077768] | (2|2) |
(2|1|0) |
| - 1: | Cuprizone [MESH:D003471] | (0|0) |
(0|0|0) |
| - 1: | Cyclohexane [MESH:C506365] | (0|0) |
(0|0|0) |
| - 1: | DS-3801b [MESH:C000627053] | (0|0) |
(0|0|0) |
| - 1: | E139 compound [MESH:C482385] | (0|0) |
(0|0|0) |
| - 1: | ETH 5234 [MESH:C547634] | (0|0) |
(0|0|0) |
| - 1: | F 1394 [MESH:C094918] | (0|0) |
(0|0|0) |
| - 1: | FLV 23-A [MESH:C066115] | (0|0) |
(0|0|0) |
| - 1: | FR 65814 [MESH:C057298] | (0|0) |
(0|0|0) |
| - 1: | GDC-0152 [MESH:C579046] | (0|0) |
(0|0|0) |
| - 1: | H 218-54 [MESH:C080611] | (0|0) |
(0|0|0) |
| - 1: | H3tachta [MESH:C421107] | (0|0) |
(0|0|0) |
| - 1: | HY52 compound [MESH:C509843] | (0|0) |
(0|0|0) |
| - 1: | KCG 1 [MESH:C077806] | (0|0) |
(0|0|0) |
| - 1: | KCG 10 [MESH:C077807] | (0|0) |
(0|0|0) |
| - 1: | L 152804 [MESH:C410588] | (0|0) |
(0|0|0) |
| - 1: | L 970843 [MESH:C447446] | (0|0) |
(0|0|0) |
| - 1: | L 970844 [MESH:C447447] | (0|0) |
(0|0|0) |
| - 1: | LAS190792 [MESH:C000627337] | (0|0) |
(0|0|0) |
| - 1: | LG 100127 [MESH:C092755] | (0|0) |
(0|0|0) |
| - 1: | LY 243670 [MESH:C070736] | (0|0) |
(0|0|0) |
| - 1: | M.G. 6669 [MESH:C036632] | (0|0) |
(0|0|0) |
| - 1: | M119 compound [MESH:C509953] | (0|0) |
(0|0|0) |
| - 1: | Maraviroc [MESH:D000077592] | (0|0) |
(0|0|0) |
| - 1: | N,N'-bis(ethoxycarbonyl)-N-(4-(3-iodo-4-methoxyphenyl)butyl)-N'-(5-phenylpentyl)-1,4-cyclohexanedime [MESH:C097717] | (0|0) |
(0|0|0) |
| - 1: | N,N'-bis-(3-aminopropyl) cyclohexane-1,4-diamine [MESH:C508894] | (0|0) |
(0|0|0) |
| - 1: | N,N'-bis-(3-aminopropyl)cyclohexane-1,4-diamine, tetramethanesulfonate [MESH:C504396] | (0|0) |
(0|0|0) |
| - 1: | N,N,N',N'-tetracyclohexyl-3-oxapentanediamide [MESH:C077946] | (0|0) |
(0|0|0) |
| - 1: | N,N-dibenzyl-cyclohexane-1,2-diamine [MESH:C558515] | (0|0) |
(0|0|0) |
| - 1: | N,N-dicyclohexyl-2-benzothiazolesulfenamide [MESH:C526935] | (0|0) |
(0|0|0) |
| - 1: | N,N-dicyclohexylamide-N'-(3-diethylaminopropyl)-N-(N-nitrobenzoyl) aminoacetic acid hydroxyoxalate [MESH:C478369] | (0|0) |
(0|0|0) |
| - 1: | N-(1-cyanocyclopropyl)-2-((4-(1,3-dimethyl-1H-indazol-5-yl)-2-methylpiperazin-1-yl)carbonyl)cyclohex [MESH:C577931] | (0|0) |
(0|0|0) |
| - 1: | N-(1-phenylcyclohexyl)-2-hydroxyethanamine [MESH:C541249] | (0|0) |
(0|0|0) |
| - 1: | N-(2,3-dichlorophenyl)cyclohexanecarboxamide [MESH:C000611744] | (0|0) |
(0|0|0) |
| - 1: | N-(2-(4-(2-methoxyphenyl)piperazino))-N-(2-pyridinyl) trans-4-fluorocyclohexanecarboxamide [MESH:C493883] | (0|0) |
(0|0|0) |
| - 1: | N-(2-(4-(2-methoxyphenyl)piperazino)ethyl)-N-2-(pyridyl)-cis-3 -fluorocyclohexanecarboxamide [MESH:C512316] | (0|0) |
(0|0|0) |
| - 1: | N-(2-chloro-4-nitrophenyl)-2-(cyclohexylcarbonyloxy)-5-chlorobenzamide [MESH:C524657] | (0|0) |
(0|0|0) |
| - 1: | N-(3-triethoxysilylpropyl)-4-(N'-maleimidylmethyl)cyclohexanamide [MESH:C522503] | (0|0) |
(0|0|0) |
| - 1: | N-(3-triethoxysilylpropyl)-4-(isothiocyanatomethyl)cyclohexane-1-carboxamide [MESH:C532456] | (0|0) |
(0|0|0) |
| - 1: | N-(cyanomethyl)-5,5-dichloro-(4'-(methylthio)-1,1'-biphenyl-2-yl)cyclohexanecarboxamide [MESH:C508997] | (0|0) |
(0|0|0) |
| - 1: | N-(cyclohexanecarboxyl)-O-phospho-serine [MESH:C407063] | (0|0) |
(0|0|0) |
| - 1: | N-Boc-N-(p-methoxyphenyl)-3-cyclohexylallylamine [MESH:C433063] | (0|0) |
(0|0|0) |
| - 1: | N-cyclohexyl-N'-dodecanoic acid [MESH:C503115] | (0|0) |
(0|0|0) |
| - 1: | N-cyclohexyl-diazeniumdioxide [MESH:C469872] | (0|0) |
(0|0|0) |
| - 1: | N1,N2-bis(2,4,6-trihydroxy-3,5-diaminocyclohexyl)ethane-1,2-diamine [MESH:C550271] | (0|0) |
(0|0|0) |
| - 1: | NPCO-DSC [MESH:C473994] | (0|0) |
(0|0|0) |
| - 1: | NTE 122 [MESH:C111531] | (0|0) |
(0|0|0) |
| - 1: | Nateglinide [MESH:D000077715] | (1|0) |
(1|0|0) |
| - 1: | O-(Chloroacetylcarbamoyl)fumagillol [MESH:D000077609] | (0|0) |
(0|0|0) |
| - 1: | Omite [MESH:C002771] | (0|0) |
(0|0|0) |
| - 1: | PB167 [MESH:C515444] | (0|0) |
(0|0|0) |
| - 1: | PD 125754 [MESH:C076647] | (0|0) |
(0|0|0) |
| - 1: | PD 125967 [MESH:C076646] | (0|0) |
(0|0|0) |
| - 1: | RK-805 [MESH:C514927] | (0|0) |
(0|0|0) |
| - 1: | Ro 25-5802 [MESH:C097598] | (0|0) |
(0|0|0) |
| - 1: | Ro 25-6603 [MESH:C097599] | (0|0) |
(0|0|0) |
| - 1: | S27847 [MESH:C512501] | (0|0) |
(0|0|0) |
| - 1: | SKF1 compound [MESH:C482297] | (0|0) |
(0|0|0) |
| - 1: | SLV320 compound [MESH:C523961] | (0|0) |
(0|0|0) |
| - 1: | SR 31747 [MESH:C088447] | (0|0) |
(0|0|0) |
| - 1: | SU-15049 [MESH:C001963] | (0|0) |
(0|0|0) |
| - 1: | TAI 998 [MESH:C047838] | (0|0) |
(0|0|0) |
| - 1: | U 49132E [MESH:C076240] | (0|0) |
(0|0|0) |
| - 1: | U 49524E [MESH:C076241] | (0|0) |
(0|0|0) |
| - 1: | V214w [MESH:C462602] | (0|0) |
(0|0|0) |
| - 1: | Vesitan [MESH:C005935] | (0|0) |
(0|0|0) |
| - 1: | WAY 101363 [MESH:C112802] | (0|0) |
(0|0|0) |
| - 1: | ZINC13451138 [MESH:C574249] | (0|0) |
(0|0|0) |
| - 1: | ampelomin A [MESH:C550397] | (0|0) |
(0|0|0) |
| - 1: | aogacillin A [MESH:C586467] | (0|0) |
(0|0|0) |
| - 1: | aogacillin B [MESH:C586466] | (0|0) |
(0|0|0) |
| - 1: | benzene oxide [MESH:C023372] | (0|0) |
(0|0|0) |
| - 1: | benzyl (1S,2R,4R)-4-(tert-butoxycarbonylamino)-2-(hydroxymethyl)cyclohexylcarbamate [MESH:C552386] | (0|0) |
(0|0|0) |
| - 1: | beta-tetrabromoethylcyclohexane [MESH:C000633587] | (0|0) |
(0|0|0) |
| - 1: | bis(4-tert-butylcyclohexyl)peroxydicarbonate [MESH:C039240] | (0|0) |
(0|0|0) |
| - 1: | bis(morpholinium 2,4,6-trinitrocyclohexanolate) [MESH:C548984] | (0|0) |
(0|0|0) |
| - 1: | boesenoxide [MESH:C497706] | (0|0) |
(0|0|0) |
| - 1: | butylcyclohexane [MESH:C474480] | (0|0) |
(0|0|0) |
| - 1: | cis,cis-1,3,5-cyclohexanetriol triphosphate [MESH:C504864] | (0|0) |
(0|0|0) |
| - 1: | cis-1,2-bis((N,N-dimethylamino)methyl) cyclohexane [MESH:C512126] | (0|0) |
(0|0|0) |
| - 1: | cis-1,3-dimethoxycyclohexane [MESH:C503817] | (0|0) |
(0|0|0) |
| - 1: | cis-2-benzamidocyclohexanecarboxylic acid [MESH:C571094] | (0|0) |
(0|0|0) |
| - 1: | cis-3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid [MESH:C528336] | (0|0) |
(0|0|0) |
| - 1: | cis-N-(4-(4-(1,2-benzisozole-3-yl)-1-piperazinyl) butyl)cyclohexane-1,2-dicarboximide monohydrochlor [MESH:C509105] | (0|0) |
(0|0|0) |
| - 1: | crispatenine [MESH:C520706] | (0|0) |
(0|0|0) |
| - 1: | cyanocyclohexane [MESH:C534428] | (0|0) |
(0|0|0) |
| - 1: | cyclobakuchiol A [MESH:C000590877] | (0|0) |
(0|0|0) |
| - 1: | cyclobakuchiol B [MESH:C000590878] | (0|0) |
(0|0|0) |
| - 1: | cyclobakuchiol C [MESH:C000590879] | (0|0) |
(0|0|0) |
| - 1: | cyclohexanaecarboxaldehyde [MESH:C032177] | (0|0) |
(0|0|0) |
| - 1: | cyclohexane-1,2,4-tris(methylenesulfonate) [MESH:C083633] | (0|0) |
(0|0|0) |
| - 1: | cyclohexane-1,2-bis(4-methyl-3-thiosemicarbazone) [MESH:C539303] | (0|0) |
(0|0|0) |
| - 1: | cyclohexane-1,3,5-tricarboxylic acid tris-((2-((2-hydroxy-benzylidene)-amino)-ethyl)-amide [MESH:C000601613] | (0|0) |
(0|0|0) |
| - 1: | cyclohexane-1,3,5-tricarboxylic acid tris-((3-((2-hydroxy-benzylidene)-amino)-propyl)-amide [MESH:C000601614] | (0|0) |
(0|0|0) |
| - 1: | cyclohexane-1-spiro-2'-(4'-oxyimidazolidine-1'-oxyl)-5'-spiro-1''-cyclohexane [MESH:C481122] | (0|0) |
(0|0|0) |
| - 1: | cyclohexaneacetic acid [MESH:C018883] | (0|0) |
(0|0|0) |
| - 1: | cyclohexanebutyric acid [MESH:C034707] | (0|0) |
(0|0|0) |
| - 1: | cyclohexenyl chalcone [MESH:C512303] | (0|0) |
(0|0|0) |
| - 1: | cyclohexylmethanol [MESH:C004707] | (0|0) |
(0|0|0) |
| - 1: | cyclohexylmethylnitrate [MESH:C482655] | (0|0) |
(0|0|0) |
| - 1: | cyclohexylphenylketone [MESH:C007195] | (0|0) |
(0|0|0) |
| - 1: | cycloxydim [MESH:C401281] | (0|0) |
(0|0|0) |
| - 1: | cyprodenate [MESH:C000027] | (0|0) |
(0|0|0) |
| - 1: | dalvastatin [MESH:C071481] | (0|0) |
(0|0|0) |
| - 1: | damascenone [MESH:C502869] | (0|0) |
(0|0|0) |
| - 1: | deacetoxyyanuthone A [MESH:C482474] | (0|0) |
(0|0|0) |
| - 1: | di-tert-butylperoxy-3,3,5-trimethylcyclohexane peroxide [MESH:C067220] | (0|0) |
(0|0|0) |
| - 1: | dicyclohexyl 2,3-epoxysuccinate [MESH:C041379] | (0|0) |
(0|0|0) |
| - 1: | dicyclohexylmethane [MESH:C049961] | (0|0) |
(0|0|0) |
| - 1: | diethyl 1,3-dicyclohexyl-1,2,3,6-tetrahydropyrimidine-4,5-dicarboxylate [MESH:C581226] | (0|0) |
(0|0|0) |
| - 1: | dimethylperfluorocylohexane [MESH:C079130] | (0|0) |
(0|0|0) |
| - 1: | dodecylcyclohexane [MESH:C014517] | (0|0) |
(0|0|0) |
| - 1: | drummondin C [MESH:C073471] | (0|0) |
(0|0|0) |
| - 1: | drummondin D [MESH:C073646] | (0|0) |
(0|0|0) |
| - 1: | drummondin E [MESH:C073628] | (0|0) |
(0|0|0) |
| - 1: | drummondin F [MESH:C073629] | (0|0) |
(0|0|0) |
| - 1: | epoxy cyclohexyl methyl-epoxy cyclo-hexane carboxylate [MESH:C470249] | (0|0) |
(0|0|0) |
| - 1: | ethyl cyclohexanoate [MESH:C517079] | (0|0) |
(0|0|0) |
| - 1: | ethylcyclohexane [MESH:C030813] | (0|0) |
(0|0|0) |
| - 1: | fumagillin [MESH:C026211] | (0|0) |
(0|0|0) |
| - 1: | fumagillol [MESH:C057299] | (0|0) |
(0|0|0) |
| - 1: | hydroxycyclohexadienyl radical [MESH:C008001] | (0|0) |
(0|0|0) |
| - 1: | incarvmarein A [MESH:C547887] | (0|0) |
(0|0|0) |
| - 1: | incarvmarein B [MESH:C547888] | (0|0) |
(0|0|0) |
| - 1: | isocyanocyclohexane [MESH:C534427] | (0|0) |
(0|0|0) |
| - 1: | isodrummondin D [MESH:C073626] | (0|0) |
(0|0|0) |
| - 1: | isopanduratin A1 [MESH:C000621551] | (0|0) |
(0|0|0) |
| - 1: | isopropylcyclohexane [MESH:C055969] | (0|0) |
(0|0|0) |
| - 1: | juvabione [MESH:C414814] | (0|0) |
(0|0|0) |
| - 1: | mebenzonium iodide [MESH:C535255] | (0|0) |
(0|0|0) |
| - 1: | megastigma-6,7-dien-3,5,9-triol 9-O-glycopyranoside [MESH:C476261] | (0|0) |
(0|0|0) |
| - 1: | methyl 1'-hydroxy-2',6'-dimethoxy-4'-oxocyclohexanacetate [MESH:C432509] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-(1-((2-((tert-butoxycarbonyl)amino)benzamido)methyl)cyclohexyl)acetate [MESH:C000588704] | (0|0) |
(0|0|0) |
| - 1: | methylcyclohexane [MESH:C521475] | (0|0) |
(0|0|0) |
| - 1: | mycosporulone [MESH:C400135] | (0|0) |
(0|0|0) |
| - 1: | omega-cyclohexyldodecanoic acid [MESH:C040447] | (0|0) |
(0|0|0) |
| - 1: | omega-cyclohexylundecanoic acid [MESH:C087539] | (0|0) |
(0|0|0) |
| - 1: | pemenone [MESH:C098308] | (0|0) |
(0|0|0) |
| - 1: | perfluoro-1,2-dimethyl cyclohexane [MESH:C528032] | (0|0) |
(0|0|0) |
| - 1: | perfluoroethylcyclohexane [MESH:C080421] | (0|0) |
(0|0|0) |
| - 1: | piperidino-1-(methylcyclohexane) [MESH:C003150] | (0|0) |
(0|0|0) |
| - 1: | platanionoside A [MESH:C121591] | (0|0) |
(0|0|0) |
| - 1: | platanionoside B [MESH:C121592] | (0|0) |
(0|0|0) |
| - 1: | platanionoside C [MESH:C121593] | (0|0) |
(0|0|0) |
| - 1: | poly (trans-1,2-cyclohexanediyl-bis acrylamide) [MESH:C502589] | (0|0) |
(0|0|0) |
| - 1: | polycyclohexane [MESH:C025467] | (0|0) |
(0|0|0) |
| - 1: | pyridoxatin [MESH:C069924] | (0|0) |
(0|0|0) |
| - 1: | simmondsin [MESH:C089377] | (0|0) |
(0|0|0) |
| - 1: | spiro(cyclohexane-1,3'(1'H)-furo(3,4-C)pyridine)-4-carboxamide, N-(1-(2-fluorophenyl)-1h-pyrazol-3-y [MESH:C515547] | (0|0) |
(0|0|0) |
| - 1: | sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboylate [MESH:C000614795] | (0|0) |
(0|0|0) |
| - 1: | surinone A [MESH:C477208] | (0|0) |
(0|0|0) |
| - 1: | surinone B [MESH:C477207] | (0|0) |
(0|0|0) |
| - 1: | surinone C [MESH:C477206] | (0|0) |
(0|0|0) |
| - 1: | tert-butylcyclohexane [MESH:C054362] | (0|0) |
(0|0|0) |
| - 1: | theobroxide [MESH:C496818] | (0|0) |
(0|0|0) |
| - 1: | trans-(1S,2S)-bis(ureidododecyl)cyclohexane [MESH:C512002] | (0|0) |
(0|0|0) |
| - 1: | trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride [MESH:D001371] | (0|0) |
(0|0|0) |
| - 1: | trans-N-4-(N'-(4-chlorobenzoyl)hydrazinocarbonyl)cyclohexylmethyl-4-bromobenzenesulfonamide [MESH:C492876] | (0|0) |
(0|0|0) |
| - 1: | trans-cyclohexyl-1,2-bisacrylate [MESH:C484623] | (0|0) |
(0|0|0) |
| - 1: | trimethyl cis,cis-1,3,5-tripropyl-1,3,5 cyclohexenetricarboxilic acid [MESH:C512889] | (0|0) |
(0|0|0) |
| - 1: | uvarigranol A [MESH:C442846] | (0|0) |
(0|0|0) |
| - 1: | zeylenone [MESH:C516240] | (0|0) |
(0|0|0) |
Jump to [ Top · Hierarchy ]
Superfamily( show details)
Highlighted in gray are those with FDR_all>0.001
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| BAG domain | 0 | DIRECT |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| Di-copper centre-containing domain | 0 | DIRECT |
| Alpha-L RNA-binding motif | 0 | DIRECT |
| Phosphoglucomutase, C-terminal domain | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Nicotinate/Quinolinate PRTase C-terminal domain-like | 0 | DIRECT |
| Alanine racemase C-terminal domain-like | 0 | DIRECT |
| PLP-binding barrel | 0 | DIRECT |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | DIRECT |
| A heparin-binding domain | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | DIRECT |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Phosphoglucomutase, first 3 domains | 0 | DIRECT |
| TNF receptor-like | 0.0000004105 | DIRECT |
| Bcl-2 inhibitors of programmed cell death | 0.000001605 | DIRECT |
| Caspase-like | 0.00001507 | DIRECT |
| Frizzled cysteine-rich domain | 0.000863 | DIRECT |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.001932 | INHERITED FROM: aurin || Cyclohexanecarboxylic Acids |
| E2F-DP heterodimerization region | 0.004817 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| p53-like transcription factors | 0.007174 | INHERITED FROM: Cyclohexanones |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.01185 | INHERITED FROM: 9-cis-retinal || 1,1-bis(4-hydroxyphenyl)cyclohexane || Fenretinide || Bexarotene || 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid || SR 11237 || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || beta Carotene || Ciclopirox || 4-hydroxyretinoic acid || diisononyl 1,2-cyclohexanedicarboxylic acid || Retinaldehyde || Cyclohexanecarboxylic Acids || Alitretinoin |
| CoA-dependent acyltransferases | 0.03177 | INHERITED FROM: Isotretinoin |
| DEATH domain | 0.04218 | INHERITED FROM: Menthol || Cyclohexanols || Fenretinide || Cyclohexane Monoterpenes || dehydroxymethylepoxyquinomicin || beta Carotene || Cyclohexanones || Acitretin |
| Inhibitor of apoptosis (IAP) repeat | 0.06282 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes || dehydroxymethylepoxyquinomicin || Cyclohexanones |
| Prefoldin | 0.0771 | INHERITED FROM: Bexarotene || 4-oxoretinol || 4-oxoretinoic acid || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || beta Carotene || Alitretinoin |
| Lipocalins | 0.09317 | INHERITED FROM: 4-oxoretinoic acid |
| TRAF domain-like | 0.1176 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| TK C-terminal domain-like | 0.124 | INHERITED FROM: Isotretinoin |
| Nuclear receptor ligand-binding domain | 0.1382 | INHERITED FROM: 9-cis-retinal || 1,1-bis(4-hydroxyphenyl)cyclohexane || Fenretinide || Bexarotene || 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid || SR 11237 || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Cyclohexenes || beta Carotene || Ciclopirox || Retinoids || 4-hydroxyretinoic acid || diisononyl 1,2-cyclohexanedicarboxylic acid || Retinaldehyde || Cyclohexanecarboxylic Acids || Alitretinoin |
| GroEL-intermediate domain like | 0.1587 | INHERITED FROM: CD 437 |
| TNF-like | 0.1626 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| Sm-like ribonucleoproteins | 0.1731 | INHERITED FROM: CD 437 |
| Thiolase-like | 0.1782 | INHERITED FROM: Isotretinoin |
| Intermediate filament protein, coiled coil region | 0.2023 | INHERITED FROM: 4-oxoretinol || 4-oxoretinoic acid || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || beta Carotene || Isotretinoin || Alitretinoin |
| BRCT domain | 0.2171 | INHERITED FROM: Fenretinide |
| Integrin domains | 0.237 | INHERITED FROM: Cyclohexenes || Retinoids |
| Cytochrome P450 | 0.2446 | INHERITED FROM: 4,4'-cyclohexylidenebisphenol || 4-oxoretinoic acid || 2-methyl-5-isopropenylcyclohex-2-enone oxime || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Limonene || Eucalyptol || 4-hydroxyretinoic acid || Alitretinoin |
| Homeodomain-like | 0.2582 | INHERITED FROM: beta Carotene || apocarotenal |
| GroEL apical domain-like | 0.2872 | INHERITED FROM: CD 437 |
| 4-helical cytokines | 0.2906 | INHERITED FROM: Cilomilast || Cyclohexanecarboxylic Acids || apocarotenal || Alitretinoin |
| Carbon-nitrogen hydrolase | 0.3287 | INHERITED FROM: Isotretinoin |
| LuxS/MPP-like metallohydrolase | 0.3287 | INHERITED FROM: Isotretinoin |
| Actin-like ATPase domain | 0.3335 | INHERITED FROM: aurin |
| RNA-binding domain, RBD | 0.3352 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| GroES-like | 0.37 | INHERITED FROM: apocarotenal |
| A DNA-binding domain in eukaryotic transcription factors | 0.404 | INHERITED FROM: Tretinoin || Vitamin A |
| Calpain large subunit, middle domain (domain III) | 0.4059 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
| Interleukin 8-like chemokines | 0.4323 | INHERITED FROM: 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol || beta Carotene |
| Cyclin-like | 0.4323 | INHERITED FROM: 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
| UDP-Glycosyltransferase/glycogen phosphorylase | 0.4587 | INHERITED FROM: Cyclohexanecarboxylic Acids |
| NAD(P)-linked oxidoreductase | 0.4789 | INHERITED FROM: 9-cis-retinal || Retinaldehyde |
| GroEL equatorial domain-like | 0.4826 | INHERITED FROM: CD 437 |
| SH2 domain | 0.486 | INHERITED FROM: 4-acetylantroquinonol B || Cyclohexanones |
| Single hybrid motif | 0.5221 | INHERITED FROM: Isotretinoin |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.5667 | INHERITED FROM: aurin || Cyclohexanecarboxylic Acids |
| SMAD MH1 domain | 0.5667 | INHERITED FROM: Cyclohexenes || Retinoids |
| Aminoacid dehydrogenase-like, N-terminal domain | 0.5667 | INHERITED FROM: Tretinoin || Vitamin A |
| NAD(P)-binding Rossmann-fold domains | 0.5824 | INHERITED FROM: Isotretinoin || Retinoids |
| GST C-terminal domain-like | 0.6145 | INHERITED FROM: apple polyphenol extract || beta Carotene || apocarotenal |
| Metalloproteases ("zincins"), catalytic domain | 0.6181 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid |
| Thyroglobulin type-1 domain | 0.6537 | INHERITED FROM: Menthol || Tretinoin || Cyclohexenes || Vitamin A || Retinoids |
| Nucleoside diphosphate kinase, NDK | 0.6707 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
| ClpP/crotonase | 0.6895 | INHERITED FROM: Isotretinoin |
| Hemopexin-like domain | 0.6895 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid || Chlorogenic Acid |
| PGBD-like | 0.7264 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid || Chlorogenic Acid || Cyclohexanecarboxylic Acids |
| BTG domain-like | 0.7294 | INHERITED FROM: LG 100815 |
| Tubulin C-terminal domain-like | 0.7631 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Tubulin nucleotide-binding domain-like | 0.7631 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Nucleic acid-binding proteins | 0.7763 | INHERITED FROM: Quinic Acid || CD 437 |
| Leucine zipper domain | 0.7763 | INHERITED FROM: Cyclohexenes || Retinoids |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.8078 | INHERITED FROM: carvone || menthone || Picrotoxin |
| Nicotinic receptor ligand binding domain-like | 0.8078 | INHERITED FROM: carvone || menthone || Picrotoxin |
| Ribosomal protein S5 domain 2-like | 0.8412 | INHERITED FROM: CD 437 |
| HD-domain/PDEase-like | 0.8693 | INHERITED FROM: Cilomilast || Cyclohexanecarboxylic Acids |
| CCCH zinc finger | 0.8801 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| ALDH-like | 0.8952 | INHERITED FROM: Retinaldehyde || apocarotenal |
| Thioredoxin-like | 0.9041 | INHERITED FROM: Quinic Acid || beta Carotene || captafol || apocarotenal |
| Cytochrome b5-like heme/steroid binding domain | 0.9089 | INHERITED FROM: Isotretinoin |
| SNF-like | 0.9089 | INHERITED FROM: Cyclohexylamines || Cyclohexanones || 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone |
| Zn-binding ribosomal proteins | 0.9433 | INHERITED FROM: CD 437 |
| Mitochondrial carrier | 0.9611 | INHERITED FROM: CD 437 |
| CAD & PB1 domains | 0.9867 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| Protein kinase-like (PK-like) | 1 | INHERITED FROM: Lycopene || 3-O-caffeoyl-1-methylquinic acid || 4-acetylantroquinonol B || beta-ionone |
| MFS general substrate transporter | 1 | INHERITED FROM: Nateglinide |
| Nucleotidylyl transferase | 1 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| S15/NS1 RNA-binding domain | 1 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| FAD/NAD(P)-binding domain | 1 | INHERITED FROM: Xanthophylls |
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| BAG domain | 0 | Direct |
| Nuclear receptor coactivator interlocking domain | 0 | Direct |
| Di-copper centre-containing domain | 0 | Direct |
| Alpha-L RNA-binding motif | 0 | Direct |
| Phosphoglucomutase, C-terminal domain | 0 | Direct |
| P-domain of calnexin/calreticulin | 0 | Direct |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
| Nicotinate/Quinolinate PRTase C-terminal domain-like | 0 | Direct |
| Alanine racemase C-terminal domain-like | 0 | Direct |
| PLP-binding barrel | 0 | Direct |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | Direct |
| A heparin-binding domain | 0 | Direct |
| p53 tetramerization domain | 0 | Direct |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | Direct |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
| Phosphoglucomutase, first 3 domains | 0 | Direct |
| TNF receptor-like | 0.0000004105 | Direct |
| Bcl-2 inhibitors of programmed cell death | 0.000001605 | Direct |
| Caspase-like | 0.00001507 | Direct |
| Frizzled cysteine-rich domain | 0.000863 | Direct |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.001932 | Inherited |
| E2F-DP heterodimerization region | 0.004817 | Inherited |
| p53-like transcription factors | 0.007174 | Inherited |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.01185 | Inherited |
| CoA-dependent acyltransferases | 0.03177 | Inherited |
| DEATH domain | 0.04218 | Inherited |
| Inhibitor of apoptosis (IAP) repeat | 0.06282 | Inherited |
| Prefoldin | 0.0771 | Inherited |
| Lipocalins | 0.09317 | Inherited |
| TRAF domain-like | 0.1176 | Inherited |
| TK C-terminal domain-like | 0.124 | Inherited |
| Nuclear receptor ligand-binding domain | 0.1382 | Inherited |
| GroEL-intermediate domain like | 0.1587 | Inherited |
| TNF-like | 0.1626 | Inherited |
| Sm-like ribonucleoproteins | 0.1731 | Inherited |
| Thiolase-like | 0.1782 | Inherited |
| Intermediate filament protein, coiled coil region | 0.2023 | Inherited |
| BRCT domain | 0.2171 | Inherited |
| Integrin domains | 0.237 | Inherited |
| Cytochrome P450 | 0.2446 | Inherited |
| Homeodomain-like | 0.2582 | Inherited |
| GroEL apical domain-like | 0.2872 | Inherited |
| 4-helical cytokines | 0.2906 | Inherited |
| Carbon-nitrogen hydrolase | 0.3287 | Inherited |
| LuxS/MPP-like metallohydrolase | 0.3287 | Inherited |
| Actin-like ATPase domain | 0.3335 | Inherited |
| RNA-binding domain, RBD | 0.3352 | Inherited |
| GroES-like | 0.37 | Inherited |
| A DNA-binding domain in eukaryotic transcription factors | 0.404 | Inherited |
| Calpain large subunit, middle domain (domain III) | 0.4059 | Inherited |
| Interleukin 8-like chemokines | 0.4323 | Inherited |
| Cyclin-like | 0.4323 | Inherited |
| UDP-Glycosyltransferase/glycogen phosphorylase | 0.4587 | Inherited |
| NAD(P)-linked oxidoreductase | 0.4789 | Inherited |
| GroEL equatorial domain-like | 0.4826 | Inherited |
| SH2 domain | 0.486 | Inherited |
| Single hybrid motif | 0.5221 | Inherited |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.5667 | Inherited |
| SMAD MH1 domain | 0.5667 | Inherited |
| Aminoacid dehydrogenase-like, N-terminal domain | 0.5667 | Inherited |
| NAD(P)-binding Rossmann-fold domains | 0.5824 | Inherited |
| GST C-terminal domain-like | 0.6145 | Inherited |
| Metalloproteases ("zincins"), catalytic domain | 0.6181 | Inherited |
| Thyroglobulin type-1 domain | 0.6537 | Inherited |
| Nucleoside diphosphate kinase, NDK | 0.6707 | Inherited |
| ClpP/crotonase | 0.6895 | Inherited |
| Hemopexin-like domain | 0.6895 | Inherited |
| PGBD-like | 0.7264 | Inherited |
| BTG domain-like | 0.7294 | Inherited |
| Tubulin C-terminal domain-like | 0.7631 | Inherited |
| Tubulin nucleotide-binding domain-like | 0.7631 | Inherited |
| Nucleic acid-binding proteins | 0.7763 | Inherited |
| Leucine zipper domain | 0.7763 | Inherited |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.8078 | Inherited |
| Nicotinic receptor ligand binding domain-like | 0.8078 | Inherited |
| Ribosomal protein S5 domain 2-like | 0.8412 | Inherited |
| HD-domain/PDEase-like | 0.8693 | Inherited |
| CCCH zinc finger | 0.8801 | Inherited |
| ALDH-like | 0.8952 | Inherited |
| Thioredoxin-like | 0.9041 | Inherited |
| Cytochrome b5-like heme/steroid binding domain | 0.9089 | Inherited |
| SNF-like | 0.9089 | Inherited |
| Zn-binding ribosomal proteins | 0.9433 | Inherited |
| Mitochondrial carrier | 0.9611 | Inherited |
| CAD & PB1 domains | 0.9867 | Inherited |
| Protein kinase-like (PK-like) | 1 | Inherited |
| MFS general substrate transporter | 1 | Inherited |
| Nucleotidylyl transferase | 1 | Inherited |
| S15/NS1 RNA-binding domain | 1 | Inherited |
| FAD/NAD(P)-binding domain | 1 | Inherited |
LINKTO: Domain2BO Download and Domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Family( show details)
Highlighted in gray are those with FDR_all>0.001
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| IP3 receptor type 1 binding core, domain 2 | 0 | DIRECT |
| Phosphoglucomutase, C-terminal domain | 0 | DIRECT |
| DEATH effector domain, DED | 0 | DIRECT |
| PAS domain of steroid receptor coactivator 1A, NCo-A1 | 0 | DIRECT |
| Oligoxyloglucan reducing end-specific cellobiohydrolase | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | DIRECT |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| p53 DNA-binding domain-like | 0 | DIRECT |
| CAT-like | 0 | DIRECT |
| Eukaryotic ODC-like | 0 | DIRECT |
| Cystathionine synthase-like | 0 | DIRECT |
| Serum paraoxonase/arylesterase 1, PON1 | 0 | DIRECT |
| Biotin dependent carboxylase carboxyltransferase domain | 0 | DIRECT |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Alanine racemase-like, N-terminal domain | 0 | DIRECT |
| Isoprenyl diphosphate synthases | 0 | DIRECT |
| 1,3-glucuronyltransferase | 0 | DIRECT |
| Calnexin/calreticulin | 0 | DIRECT |
| Malic enzyme N-domain | 0 | DIRECT |
| A heparin-binding domain | 0 | DIRECT |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | DIRECT |
| BAG domain | 0 | DIRECT |
| Phosphoglucomutase, first 3 domains | 0 | DIRECT |
| TNF receptor-like | 0.00000005137 | DIRECT |
| Caspase recruitment domain, CARD | 0.0000003887 | DIRECT |
| Bcl-2 inhibitors of programmed cell death | 0.000002187 | DIRECT |
| Caspase catalytic domain | 0.000006227 | DIRECT |
| Laminin G-like module | 0.0003783 | DIRECT |
| C2 set domains | 0.0003818 | DIRECT |
| Glutathione S-transferase (GST), N-terminal domain | 0.0006383 | DIRECT |
| Frizzled cysteine-rich domain | 0.001209 | INHERITED FROM: Tretinoin || Vitamin A |
| DEATH domain, DD | 0.001447 | INHERITED FROM: Cyclohexanols || Cyclohexane Monoterpenes || beta Carotene || apocarotenal |
| Short-chain cytokines | 0.001451 | INHERITED FROM: Cyclohexenes || Retinoids || Cyclohexanecarboxylic Acids || Alitretinoin |
| MIF4G domain-like | 0.002269 | INHERITED FROM: Tretinoin || Vitamin A |
| Integrin alpha N-terminal domain | 0.002516 | INHERITED FROM: Cyclohexenes || Retinoids |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.005462 | INHERITED FROM: Cyclohexanecarboxylic Acids |
| E2F dimerization segment | 0.007293 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
| CAD domain | 0.01858 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| Inhibitor of apoptosis (IAP) repeat | 0.06711 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes || dehydroxymethylepoxyquinomicin || Cyclohexanones |
| Branched-chain alpha-keto acid dehydrogenase beta-subunit, C-terminal-domain | 0.1259 | INHERITED FROM: Isotretinoin |
| EGF-type module | 0.1272 | INHERITED FROM: Retinoids || Chlorogenic Acid |
| Nuclear receptor ligand-binding domain | 0.1449 | INHERITED FROM: 9-cis-retinal || 1,1-bis(4-hydroxyphenyl)cyclohexane || Fenretinide || Bexarotene || 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid || SR 11237 || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Cyclohexenes || beta Carotene || Ciclopirox || Retinoids || 4-hydroxyretinoic acid || diisononyl 1,2-cyclohexanedicarboxylic acid || Retinaldehyde || Cyclohexanecarboxylic Acids || Alitretinoin |
| Growth factor receptor domain | 0.1562 | INHERITED FROM: Cyclohexenes |
| Nuclear receptor | 0.1684 | INHERITED FROM: 9-cis-retinal || 1,1-bis(4-hydroxyphenyl)cyclohexane || Fenretinide || Bexarotene || 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid || SR 11237 || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Cyclohexenes || beta Carotene || Ciclopirox || Retinoids || 4-hydroxyretinoic acid || diisononyl 1,2-cyclohexanedicarboxylic acid || Retinaldehyde || Cyclohexanecarboxylic Acids || Alitretinoin |
| MATH domain | 0.1707 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| Canonical RBD | 0.1718 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Intermediate filament protein, coiled coil region | 0.2092 | INHERITED FROM: 4-oxoretinol || 4-oxoretinoic acid || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || beta Carotene || Isotretinoin || Alitretinoin |
| Penta-EF-hand proteins | 0.2107 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| Glutathione S-transferase (GST), C-terminal domain | 0.216 | INHERITED FROM: apple polyphenol extract || beta Carotene || apocarotenal |
| Thiolase-related | 0.2263 | INHERITED FROM: Isotretinoin |
| TNF-like | 0.2278 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| Homeodomain | 0.2345 | INHERITED FROM: beta Carotene || apocarotenal |
| Integrin domains | 0.236 | INHERITED FROM: Cyclohexenes || Retinoids |
| Actin/HSP70 | 0.2448 | INHERITED FROM: aurin || Cyclohexanecarboxylic Acids |
| Cytochrome P450 | 0.2722 | INHERITED FROM: 4,4'-cyclohexylidenebisphenol || 4-oxoretinoic acid || 2-methyl-5-isopropenylcyclohex-2-enone oxime || Limonene || Eucalyptol || 4-hydroxyretinoic acid |
| MPP-like | 0.3339 | INHERITED FROM: Isotretinoin |
| Group II chaperonin (CCT, TRIC), apical domain | 0.3429 | INHERITED FROM: CD 437 |
| Sm motif of small nuclear ribonucleoproteins, SNRNP | 0.388 | INHERITED FROM: CD 437 |
| Alcohol dehydrogenase-like, N-terminal domain | 0.3977 | INHERITED FROM: apocarotenal |
| Alcohol dehydrogenase-like, C-terminal domain | 0.3977 | INHERITED FROM: apocarotenal |
| A DNA-binding domain in eukaryotic transcription factors | 0.3977 | INHERITED FROM: Tretinoin || Vitamin A |
| Calpain large subunit, middle domain (domain III) | 0.424 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
| Interleukin 8-like chemokines | 0.4347 | INHERITED FROM: 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol || beta Carotene |
| Interferons/interleukin-10 (IL-10) | 0.4714 | INHERITED FROM: beta Carotene || apocarotenal |
| Aldo-keto reductases (NADP) | 0.4714 | INHERITED FROM: 9-cis-retinal || Retinaldehyde |
| UDPGT-like | 0.4714 | INHERITED FROM: Cyclohexanecarboxylic Acids |
| Group II chaperonin (CCT, TRIC), ATPase domain | 0.4786 | INHERITED FROM: CD 437 |
| SH2 domain | 0.5111 | INHERITED FROM: 4-acetylantroquinonol B || Cyclohexanones |
| Cell cycle transcription factor e2f-dp | 0.5122 | INHERITED FROM: Menthol || Cyclohexanols || Cyclohexane Monoterpenes |
| Biotinyl/lipoyl-carrier proteins and domains | 0.5122 | INHERITED FROM: Isotretinoin |
| Cyclin | 0.5504 | INHERITED FROM: 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
| SMAD MH1 domain | 0.5563 | INHERITED FROM: Cyclohexenes || Retinoids |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.5563 | INHERITED FROM: aurin || Cyclohexanecarboxylic Acids |
| SMAD domain | 0.5563 | INHERITED FROM: Cyclohexenes || Retinoids |
| Calpain large subunit, catalytic domain (domain II) | 0.5774 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
| Prefoldin | 0.5774 | INHERITED FROM: 4-oxoretinoic acid || Alitretinoin |
| Matrix metalloproteases, catalytic domain | 0.5825 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid || Chlorogenic Acid |
| Tyrosine-dependent oxidoreductases | 0.6213 | INHERITED FROM: Isotretinoin |
| Thyroglobulin type-1 domain | 0.6498 | INHERITED FROM: Menthol || Tretinoin || Cyclohexenes || Vitamin A || Retinoids |
| Nucleoside diphosphate kinase, NDK | 0.6575 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
| Hemopexin-like domain | 0.6857 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid || Chlorogenic Acid |
| BTG domain-like | 0.7162 | INHERITED FROM: LG 100815 |
| MMP N-terminal domain | 0.7223 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid || Chlorogenic Acid || Cyclohexanecarboxylic Acids |
| Tubulin, GTPase domain | 0.7591 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Tubulin, C-terminal domain | 0.7591 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Translational machinery components | 0.7778 | INHERITED FROM: CD 437 |
| Leucine zipper domain | 0.787 | INHERITED FROM: Cyclohexenes || Retinoids |
| Nicotinic receptor ligand binding domain-like | 0.8212 | INHERITED FROM: carvone || menthone || Picrotoxin |
| S100 proteins | 0.8319 | INHERITED FROM: 4-oxoretinoic acid || Alitretinoin |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.8512 | INHERITED FROM: carvone || menthone || Picrotoxin |
| ALDH-like | 0.895 | INHERITED FROM: Retinaldehyde || apocarotenal |
| PDEase | 0.895 | INHERITED FROM: Cilomilast || Cyclohexanecarboxylic Acids |
| SNF-like | 0.9043 | INHERITED FROM: Cyclohexylamines || Cyclohexanones || 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone |
| CCCH zinc finger | 0.9073 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Cytochrome b5 | 0.9387 | INHERITED FROM: Isotretinoin |
| Mitochondrial carrier | 0.9648 | INHERITED FROM: CD 437 |
| a tRNA synthase domain | 0.9986 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol || Cyclohexanols |
| Protein kinases, catalytic subunit | 1 | INHERITED FROM: Lycopene || 3-O-caffeoyl-1-methylquinic acid || beta-ionone |
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Nuclear receptor coactivator interlocking domain | 0 | Direct |
| p53 tetramerization domain | 0 | Direct |
| IP3 receptor type 1 binding core, domain 2 | 0 | Direct |
| Phosphoglucomutase, C-terminal domain | 0 | Direct |
| DEATH effector domain, DED | 0 | Direct |
| PAS domain of steroid receptor coactivator 1A, NCo-A1 | 0 | Direct |
| Oligoxyloglucan reducing end-specific cellobiohydrolase | 0 | Direct |
| P-domain of calnexin/calreticulin | 0 | Direct |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | Direct |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
| p53 DNA-binding domain-like | 0 | Direct |
| CAT-like | 0 | Direct |
| Eukaryotic ODC-like | 0 | Direct |
| Cystathionine synthase-like | 0 | Direct |
| Serum paraoxonase/arylesterase 1, PON1 | 0 | Direct |
| Biotin dependent carboxylase carboxyltransferase domain | 0 | Direct |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
| Alanine racemase-like, N-terminal domain | 0 | Direct |
| Isoprenyl diphosphate synthases | 0 | Direct |
| 1,3-glucuronyltransferase | 0 | Direct |
| Calnexin/calreticulin | 0 | Direct |
| Malic enzyme N-domain | 0 | Direct |
| A heparin-binding domain | 0 | Direct |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | Direct |
| BAG domain | 0 | Direct |
| Phosphoglucomutase, first 3 domains | 0 | Direct |
| TNF receptor-like | 0.00000005137 | Direct |
| Caspase recruitment domain, CARD | 0.0000003887 | Direct |
| Bcl-2 inhibitors of programmed cell death | 0.000002187 | Direct |
| Caspase catalytic domain | 0.000006227 | Direct |
| Laminin G-like module | 0.0003783 | Direct |
| C2 set domains | 0.0003818 | Direct |
| Glutathione S-transferase (GST), N-terminal domain | 0.0006383 | Direct |
| Frizzled cysteine-rich domain | 0.001209 | Inherited |
| DEATH domain, DD | 0.001447 | Inherited |
| Short-chain cytokines | 0.001451 | Inherited |
| MIF4G domain-like | 0.002269 | Inherited |
| Integrin alpha N-terminal domain | 0.002516 | Inherited |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.005462 | Inherited |
| E2F dimerization segment | 0.007293 | Inherited |
| CAD domain | 0.01858 | Inherited |
| Inhibitor of apoptosis (IAP) repeat | 0.06711 | Inherited |
| Branched-chain alpha-keto acid dehydrogenase beta-subunit, C-terminal-domain | 0.1259 | Inherited |
| EGF-type module | 0.1272 | Inherited |
| Nuclear receptor ligand-binding domain | 0.1449 | Inherited |
| Growth factor receptor domain | 0.1562 | Inherited |
| Nuclear receptor | 0.1684 | Inherited |
| MATH domain | 0.1707 | Inherited |
| Canonical RBD | 0.1718 | Inherited |
| Intermediate filament protein, coiled coil region | 0.2092 | Inherited |
| Penta-EF-hand proteins | 0.2107 | Inherited |
| Glutathione S-transferase (GST), C-terminal domain | 0.216 | Inherited |
| Thiolase-related | 0.2263 | Inherited |
| TNF-like | 0.2278 | Inherited |
| Homeodomain | 0.2345 | Inherited |
| Integrin domains | 0.236 | Inherited |
| Actin/HSP70 | 0.2448 | Inherited |
| Cytochrome P450 | 0.2722 | Inherited |
| MPP-like | 0.3339 | Inherited |
| Group II chaperonin (CCT, TRIC), apical domain | 0.3429 | Inherited |
| Sm motif of small nuclear ribonucleoproteins, SNRNP | 0.388 | Inherited |
| Alcohol dehydrogenase-like, N-terminal domain | 0.3977 | Inherited |
| Alcohol dehydrogenase-like, C-terminal domain | 0.3977 | Inherited |
| A DNA-binding domain in eukaryotic transcription factors | 0.3977 | Inherited |
| Calpain large subunit, middle domain (domain III) | 0.424 | Inherited |
| Interleukin 8-like chemokines | 0.4347 | Inherited |
| Interferons/interleukin-10 (IL-10) | 0.4714 | Inherited |
| Aldo-keto reductases (NADP) | 0.4714 | Inherited |
| UDPGT-like | 0.4714 | Inherited |
| Group II chaperonin (CCT, TRIC), ATPase domain | 0.4786 | Inherited |
| SH2 domain | 0.5111 | Inherited |
| Cell cycle transcription factor e2f-dp | 0.5122 | Inherited |
| Biotinyl/lipoyl-carrier proteins and domains | 0.5122 | Inherited |
| Cyclin | 0.5504 | Inherited |
| SMAD MH1 domain | 0.5563 | Inherited |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.5563 | Inherited |
| SMAD domain | 0.5563 | Inherited |
| Calpain large subunit, catalytic domain (domain II) | 0.5774 | Inherited |
| Prefoldin | 0.5774 | Inherited |
| Matrix metalloproteases, catalytic domain | 0.5825 | Inherited |
| Tyrosine-dependent oxidoreductases | 0.6213 | Inherited |
| Thyroglobulin type-1 domain | 0.6498 | Inherited |
| Nucleoside diphosphate kinase, NDK | 0.6575 | Inherited |
| Hemopexin-like domain | 0.6857 | Inherited |
| BTG domain-like | 0.7162 | Inherited |
| MMP N-terminal domain | 0.7223 | Inherited |
| Tubulin, GTPase domain | 0.7591 | Inherited |
| Tubulin, C-terminal domain | 0.7591 | Inherited |
| Translational machinery components | 0.7778 | Inherited |
| Leucine zipper domain | 0.787 | Inherited |
| Nicotinic receptor ligand binding domain-like | 0.8212 | Inherited |
| S100 proteins | 0.8319 | Inherited |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.8512 | Inherited |
| ALDH-like | 0.895 | Inherited |
| PDEase | 0.895 | Inherited |
| SNF-like | 0.9043 | Inherited |
| CCCH zinc finger | 0.9073 | Inherited |
| Cytochrome b5 | 0.9387 | Inherited |
| Mitochondrial carrier | 0.9648 | Inherited |
| a tRNA synthase domain | 0.9986 | Inherited |
| Protein kinases, catalytic subunit | 1 | Inherited |
LINKTO: Domain2BO Download and Domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Single)( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Single) |
FDR (all) |
Annotation (direct or inherited) |
| BAG domain | 0 | DIRECT |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | DIRECT |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | DIRECT |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Di-copper centre-containing domain | 0 | DIRECT |
| Phosphoglucomutase, C-terminal domain | 0 | DIRECT |
| Phosphoglucomutase, first 3 domains | 0 | DIRECT |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| PLP-binding barrel | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| Alpha-L RNA-binding motif | 0 | DIRECT |
| Nicotinate/Quinolinate PRTase C-terminal domain-like | 0 | DIRECT |
| Alanine racemase C-terminal domain-like | 0 | DIRECT |
| A heparin-binding domain | 0 | DIRECT |
| TNF receptor-like | 0.0000001848 | DIRECT |
| Bcl-2 inhibitors of programmed cell death | 0.0000007479 | DIRECT |
| Caspase-like | 0.00000751 | DIRECT |
| Frizzled cysteine-rich domain | 0.0005112 | DIRECT |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.001193 | INHERITED FROM: aurin || Cyclohexanecarboxylic Acids |
| E2F-DP heterodimerization region | 0.003114 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
| p53-like transcription factors | 0.004745 | INHERITED FROM: Cyclohexanones |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.008062 | INHERITED FROM: 1,1-bis(4-hydroxyphenyl)cyclohexane || Fenretinide || 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid || Bexarotene || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || diisononyl 1,2-cyclohexanedicarboxylic acid || beta Carotene || 4-hydroxyretinoic acid || 9-cis-retinal || Alitretinoin || Retinaldehyde || Cyclohexanecarboxylic Acids || Ciclopirox || SR 11237 |
| CoA-dependent acyltransferases | 0.02292 | INHERITED FROM: Isotretinoin |
| DEATH domain | 0.0309 | INHERITED FROM: Cyclohexanols || Menthol || Fenretinide || beta Carotene || Acitretin || dehydroxymethylepoxyquinomicin || Cyclohexanones || Cyclohexane Monoterpenes |
| Inhibitor of apoptosis (IAP) repeat | 0.04703 | INHERITED FROM: Menthol || dehydroxymethylepoxyquinomicin || Cyclohexanones || Cyclohexane Monoterpenes |
| Prefoldin | 0.05846 | INHERITED FROM: 4-oxoretinoic acid || Bexarotene || 4-oxoretinol || beta Carotene || Alitretinoin || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
| Lipocalins | 0.07132 | INHERITED FROM: 4-oxoretinoic acid |
| TRAF domain-like | 0.09117 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
| TK C-terminal domain-like | 0.09645 | INHERITED FROM: Isotretinoin |
| Nuclear receptor ligand-binding domain | 0.1082 | INHERITED FROM: 1,1-bis(4-hydroxyphenyl)cyclohexane || Cyclohexenes || Fenretinide || 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid || Bexarotene || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || diisononyl 1,2-cyclohexanedicarboxylic acid || beta Carotene || 4-hydroxyretinoic acid || 9-cis-retinal || Alitretinoin || Retinaldehyde || Cyclohexanecarboxylic Acids || Retinoids || Ciclopirox || SR 11237 || Carotenoids |
| GroEL-intermediate domain like | 0.1254 | INHERITED FROM: CD 437 |
| TNF-like | 0.1286 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
| Sm-like ribonucleoproteins | 0.1375 | INHERITED FROM: CD 437 |
| Thiolase-like | 0.1419 | INHERITED FROM: Isotretinoin |
| Cystine-knot cytokines | 0.1502 | INHERITED FROM: Alitretinoin |
| Intermediate filament protein, coiled coil region | 0.1626 | INHERITED FROM: 4-oxoretinoic acid || 4-oxoretinol || beta Carotene || Isotretinoin || Alitretinoin || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
| BRCT domain | 0.1753 | INHERITED FROM: Fenretinide |
| Integrin domains | 0.1926 | INHERITED FROM: Cyclohexenes || Retinoids |
| Cytochrome P450 | 0.1993 | INHERITED FROM: Limonene || 2-methyl-5-isopropenylcyclohex-2-enone oxime || 4-oxoretinoic acid || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || 4-hydroxyretinoic acid || Alitretinoin || 4,4'-cyclohexylidenebisphenol || Eucalyptol |
| Homeodomain-like | 0.2113 | INHERITED FROM: apocarotenal || beta Carotene |
| GroEL apical domain-like | 0.2366 | INHERITED FROM: CD 437 |
| 4-helical cytokines | 0.2396 | INHERITED FROM: apocarotenal || Alitretinoin || Cyclohexanecarboxylic Acids || Cilomilast |
| LuxS/MPP-like metallohydrolase | 0.2742 | INHERITED FROM: Isotretinoin |
| Carbon-nitrogen hydrolase | 0.2742 | INHERITED FROM: Isotretinoin |
| Actin-like ATPase domain | 0.2785 | INHERITED FROM: aurin |
| RNA-binding domain, RBD | 0.2801 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| GroES-like | 0.3117 | INHERITED FROM: apocarotenal |
| A DNA-binding domain in eukaryotic transcription factors | 0.3425 | INHERITED FROM: Vitamin A || Tretinoin || Retinoids |
| Thiamin diphosphate-binding fold (THDP-binding) | 0.3443 | INHERITED FROM: Isotretinoin |
| Calpain large subunit, middle domain (domain III) | 0.3443 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
| Cyclin-like | 0.3689 | INHERITED FROM: Fenretinide || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
| Interleukin 8-like chemokines | 0.3689 | INHERITED FROM: beta Carotene || 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
| UDP-Glycosyltransferase/glycogen phosphorylase | 0.3935 | INHERITED FROM: Cyclohexanecarboxylic Acids |
| NAD(P)-linked oxidoreductase | 0.4128 | INHERITED FROM: 9-cis-retinal || Retinaldehyde |
| GroEL equatorial domain-like | 0.4164 | INHERITED FROM: CD 437 |
| SH2 domain | 0.4194 | INHERITED FROM: 4-acetylantroquinonol B || Cyclohexanones |
| Serpins | 0.4228 | INHERITED FROM: Alitretinoin |
| Single hybrid motif | 0.4539 | INHERITED FROM: Isotretinoin |
| SMAD MH1 domain | 0.496 | INHERITED FROM: Cyclohexenes || Retinoids |
| Aminoacid dehydrogenase-like, N-terminal domain | 0.496 | INHERITED FROM: Vitamin A || Tretinoin |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.496 | INHERITED FROM: aurin || Cyclohexanecarboxylic Acids |
| NAD(P)-binding Rossmann-fold domains | 0.5116 | INHERITED FROM: Isotretinoin || Retinoids |
| GST C-terminal domain-like | 0.5431 | INHERITED FROM: apocarotenal || apple polyphenol extract || beta Carotene |
| Metalloproteases ("zincins"), catalytic domain | 0.5467 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid |
| Thyroglobulin type-1 domain | 0.5821 | INHERITED FROM: Cyclohexenes || Menthol || Vitamin A || Tretinoin || Retinoids |
| Nucleoside diphosphate kinase, NDK | 0.5989 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
| ClpP/crotonase | 0.6178 | INHERITED FROM: Isotretinoin |
| Hemopexin-like domain | 0.6178 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid || Chlorogenic Acid |
| PGBD-like | 0.655 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid || Chlorogenic Acid || Cyclohexanecarboxylic Acids |
| BTG domain-like | 0.6579 | INHERITED FROM: LG 100815 |
| Tubulin nucleotide-binding domain-like | 0.6922 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Tubulin C-terminal domain-like | 0.6922 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Nucleic acid-binding proteins | 0.7062 | INHERITED FROM: Quinic Acid || CD 437 |
| Leucine zipper domain | 0.7062 | INHERITED FROM: Cyclohexenes || LG 100815 || Retinoids |
| MHC antigen-recognition domain | 0.7159 | INHERITED FROM: Isotretinoin |
| Nicotinic receptor ligand binding domain-like | 0.739 | INHERITED FROM: carvone || menthone || Picrotoxin |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.739 | INHERITED FROM: carvone || menthone || Picrotoxin |
| Ribosomal protein S5 domain 2-like | 0.7744 | INHERITED FROM: CD 437 |
| HD-domain/PDEase-like | 0.8041 | INHERITED FROM: Cyclohexanecarboxylic Acids || Cilomilast |
| CCCH zinc finger | 0.8157 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| ALDH-like | 0.8319 | INHERITED FROM: apocarotenal || Retinaldehyde |
| Thioredoxin-like | 0.8414 | INHERITED FROM: captafol || apocarotenal || apple polyphenol extract || Quinic Acid || beta Carotene |
| Cytochrome b5-like heme/steroid binding domain | 0.8467 | INHERITED FROM: Isotretinoin |
| SNF-like | 0.8467 | INHERITED FROM: Cyclohexylamines || 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone || Cyclohexanones |
| Zn-binding ribosomal proteins | 0.8842 | INHERITED FROM: CD 437 |
| Mitochondrial carrier | 0.9043 | INHERITED FROM: CD 437 |
| CAD & PB1 domains | 0.9334 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
| FAD/NAD(P)-binding domain | 0.9717 | INHERITED FROM: Xanthophylls |
| MFS general substrate transporter | 0.9778 | INHERITED FROM: Nateglinide |
| Protein kinase-like (PK-like) | 0.9878 | INHERITED FROM: Lycopene || 3-O-caffeoyl-1-methylquinic acid || beta-ionone || 4-acetylantroquinonol B || Cyclohexane Monoterpenes |
| Nucleotidylyl transferase | 0.9976 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| S15/NS1 RNA-binding domain | 0.9996 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
| Supra-domain (Single) |
FDR (all) |
Annotation (direct or inherited) |
| BAG domain | 0 | Direct |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | Direct |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | Direct |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
| Di-copper centre-containing domain | 0 | Direct |
| Phosphoglucomutase, C-terminal domain | 0 | Direct |
| Phosphoglucomutase, first 3 domains | 0 | Direct |
| Nuclear receptor coactivator interlocking domain | 0 | Direct |
| PLP-binding barrel | 0 | Direct |
| P-domain of calnexin/calreticulin | 0 | Direct |
| p53 tetramerization domain | 0 | Direct |
| Alpha-L RNA-binding motif | 0 | Direct |
| Nicotinate/Quinolinate PRTase C-terminal domain-like | 0 | Direct |
| Alanine racemase C-terminal domain-like | 0 | Direct |
| A heparin-binding domain | 0 | Direct |
| TNF receptor-like | 0.0000001848 | Direct |
| Bcl-2 inhibitors of programmed cell death | 0.0000007479 | Direct |
| Caspase-like | 0.00000751 | Direct |
| Frizzled cysteine-rich domain | 0.0005112 | Direct |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.001193 | Inherited |
| E2F-DP heterodimerization region | 0.003114 | Inherited |
| p53-like transcription factors | 0.004745 | Inherited |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.008062 | Inherited |
| CoA-dependent acyltransferases | 0.02292 | Inherited |
| DEATH domain | 0.0309 | Inherited |
| Inhibitor of apoptosis (IAP) repeat | 0.04703 | Inherited |
| Prefoldin | 0.05846 | Inherited |
| Lipocalins | 0.07132 | Inherited |
| TRAF domain-like | 0.09117 | Inherited |
| TK C-terminal domain-like | 0.09645 | Inherited |
| Nuclear receptor ligand-binding domain | 0.1082 | Inherited |
| GroEL-intermediate domain like | 0.1254 | Inherited |
| TNF-like | 0.1286 | Inherited |
| Sm-like ribonucleoproteins | 0.1375 | Inherited |
| Thiolase-like | 0.1419 | Inherited |
| Cystine-knot cytokines | 0.1502 | Inherited |
| Intermediate filament protein, coiled coil region | 0.1626 | Inherited |
| BRCT domain | 0.1753 | Inherited |
| Integrin domains | 0.1926 | Inherited |
| Cytochrome P450 | 0.1993 | Inherited |
| Homeodomain-like | 0.2113 | Inherited |
| GroEL apical domain-like | 0.2366 | Inherited |
| 4-helical cytokines | 0.2396 | Inherited |
| LuxS/MPP-like metallohydrolase | 0.2742 | Inherited |
| Carbon-nitrogen hydrolase | 0.2742 | Inherited |
| Actin-like ATPase domain | 0.2785 | Inherited |
| RNA-binding domain, RBD | 0.2801 | Inherited |
| GroES-like | 0.3117 | Inherited |
| A DNA-binding domain in eukaryotic transcription factors | 0.3425 | Inherited |
| Thiamin diphosphate-binding fold (THDP-binding) | 0.3443 | Inherited |
| Calpain large subunit, middle domain (domain III) | 0.3443 | Inherited |
| Cyclin-like | 0.3689 | Inherited |
| Interleukin 8-like chemokines | 0.3689 | Inherited |
| UDP-Glycosyltransferase/glycogen phosphorylase | 0.3935 | Inherited |
| NAD(P)-linked oxidoreductase | 0.4128 | Inherited |
| GroEL equatorial domain-like | 0.4164 | Inherited |
| SH2 domain | 0.4194 | Inherited |
| Serpins | 0.4228 | Inherited |
| Single hybrid motif | 0.4539 | Inherited |
| SMAD MH1 domain | 0.496 | Inherited |
| Aminoacid dehydrogenase-like, N-terminal domain | 0.496 | Inherited |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.496 | Inherited |
| NAD(P)-binding Rossmann-fold domains | 0.5116 | Inherited |
| GST C-terminal domain-like | 0.5431 | Inherited |
| Metalloproteases ("zincins"), catalytic domain | 0.5467 | Inherited |
| Thyroglobulin type-1 domain | 0.5821 | Inherited |
| Nucleoside diphosphate kinase, NDK | 0.5989 | Inherited |
| ClpP/crotonase | 0.6178 | Inherited |
| Hemopexin-like domain | 0.6178 | Inherited |
| PGBD-like | 0.655 | Inherited |
| BTG domain-like | 0.6579 | Inherited |
| Tubulin nucleotide-binding domain-like | 0.6922 | Inherited |
| Tubulin C-terminal domain-like | 0.6922 | Inherited |
| Nucleic acid-binding proteins | 0.7062 | Inherited |
| Leucine zipper domain | 0.7062 | Inherited |
| MHC antigen-recognition domain | 0.7159 | Inherited |
| Nicotinic receptor ligand binding domain-like | 0.739 | Inherited |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.739 | Inherited |
| Ribosomal protein S5 domain 2-like | 0.7744 | Inherited |
| HD-domain/PDEase-like | 0.8041 | Inherited |
| CCCH zinc finger | 0.8157 | Inherited |
| ALDH-like | 0.8319 | Inherited |
| Thioredoxin-like | 0.8414 | Inherited |
| Cytochrome b5-like heme/steroid binding domain | 0.8467 | Inherited |
| SNF-like | 0.8467 | Inherited |
| Zn-binding ribosomal proteins | 0.8842 | Inherited |
| Mitochondrial carrier | 0.9043 | Inherited |
| CAD & PB1 domains | 0.9334 | Inherited |
| FAD/NAD(P)-binding domain | 0.9717 | Inherited |
| MFS general substrate transporter | 0.9778 | Inherited |
| Protein kinase-like (PK-like) | 0.9878 | Inherited |
| Nucleotidylyl transferase | 0.9976 | Inherited |
| S15/NS1 RNA-binding domain | 0.9996 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Duplex) in N- to C-terminal order( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
51045,47473
51045 - WW domain
47473 - EF-hand | 0 | DIRECT |
56491,89811
56491 - A heparin-binding domain
89811 - Amyloid beta a4 protein copper binding domain (domain 2) | 0 | DIRECT |
53738,55957
53738 - Phosphoglucomutase, first 3 domains
55957 - Phosphoglucomutase, C-terminal domain | 0 | DIRECT |
53738,53738
53738 - Phosphoglucomutase, first 3 domains
53738 - Phosphoglucomutase, first 3 domains | 0 | DIRECT |
49695,50370
49695 - gamma-Crystallin-like
50370 - Ricin B-like lectins | 0 | DIRECT |
47986,52129
47986 - DEATH domain
52129 - Caspase-like | 0 | DIRECT |
46966,51045
46966 - Spectrin repeat
51045 - WW domain | 0 | DIRECT |
52540,47917
52540 - P-loop containing nucleoside triphosphate hydrolases
47917 - C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
47986,47986
47986 - DEATH domain
47986 - DEATH domain | 0 | DIRECT |
49899,63887
49899 - Concanavalin A-like lectins/glucanases
63887 - P-domain of calnexin/calreticulin | 0 | DIRECT |
69572,69572
69572 - Activating enzymes of the ubiquitin-like proteins
69572 - Activating enzymes of the ubiquitin-like proteins | 0 | DIRECT |
49899,48726
49899 - Concanavalin A-like lectins/glucanases
48726 - Immunoglobulin | 0 | DIRECT |
49417,47719
49417 - p53-like transcription factors
47719 - p53 tetramerization domain | 0 | DIRECT |
57196,57535
57196 - EGF/Laminin
57535 - Complement control module/SCR domain | 0 | DIRECT |
57924,57924
57924 - Inhibitor of apoptosis (IAP) repeat
57924 - Inhibitor of apoptosis (IAP) repeat | 0 | DIRECT |
49562,57889
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
57889 - Cysteine-rich domain | 0 | DIRECT |
51419,50621
51419 - PLP-binding barrel
50621 - Alanine racemase C-terminal domain-like | 0 | DIRECT |
100920,100934
100920 - Heat shock protein 70kD (HSP70), peptide-binding domain
100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain | 0 | DIRECT |
53300,49899
53300 - vWA-like
49899 - Concanavalin A-like lectins/glucanases | 0 | DIRECT |
57586,57586
57586 - TNF receptor-like
57586 - TNF receptor-like | 0.000000002751 | DIRECT |
52799,52799
52799 - (Phosphotyrosine protein) phosphatases II
52799 - (Phosphotyrosine protein) phosphatases II | 0.0000007479 | DIRECT |
69179,69179
69179 - Integrin domains
69179 - Integrin domains | 0.0004537 | DIRECT |
69318,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains | 0.0004537 | DIRECT |
52833,47616
52833 - Thioredoxin-like
47616 - GST C-terminal domain-like | 0.0005565 | DIRECT |
53067,100920
53067 - Actin-like ATPase domain
100920 - Heat shock protein 70kD (HSP70), peptide-binding domain | 0.001193 | INHERITED FROM: aurin || Cyclohexanecarboxylic Acids |
57850,49599
57850 - RING/U-box
49599 - TRAF domain-like | 0.001741 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
46785,144074
46785 - "Winged helix" DNA-binding domain
144074 - E2F-DP heterodimerization region | 0.003114 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
57184,57610
57184 - Growth factor receptor domain
57610 - Thyroglobulin type-1 domain | 0.004518 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
49785,49785
49785 - Galactose-binding domain-like
49785 - Galactose-binding domain-like | 0.007873 | INHERITED FROM: Menthol |
50729,56112
50729 - PH domain-like
56112 - Protein kinase-like (PK-like) | 0.007873 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
46579,64593
46579 - Prefoldin
64593 - Intermediate filament protein, coiled coil region | 0.009865 | INHERITED FROM: 4-oxoretinoic acid || Bexarotene || 4-oxoretinol || beta Carotene || Isotretinoin || Alitretinoin || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
56112,56112
56112 - Protein kinase-like (PK-like)
56112 - Protein kinase-like (PK-like) | 0.02292 | INHERITED FROM: Lycopene |
57716,48508
57716 - Glucocorticoid receptor-like (DNA-binding domain)
48508 - Nuclear receptor ligand-binding domain | 0.09594 | INHERITED FROM: 1,1-bis(4-hydroxyphenyl)cyclohexane || Cyclohexenes || Fenretinide || Vitamin A || Bexarotene || Tretinoin || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || diisononyl 1,2-cyclohexanedicarboxylic acid || Alitretinoin || Cyclohexanecarboxylic Acids || Cyclohexanones || Retinoids || Ciclopirox || SR 11237 || Carotenoids |
52518,52922
52518 - Thiamin diphosphate-binding fold (THDP-binding)
52922 - TK C-terminal domain-like | 0.09645 | INHERITED FROM: Isotretinoin |
57196,57196
57196 - EGF/Laminin
57196 - EGF/Laminin | 0.0976 | INHERITED FROM: Cyclohexenes |
54849,52029
54849 - GroEL-intermediate domain like
52029 - GroEL apical domain-like | 0.1254 | INHERITED FROM: CD 437 |
53067,53067
53067 - Actin-like ATPase domain
53067 - Actin-like ATPase domain | 0.1995 | INHERITED FROM: aurin |
48592,54849
48592 - GroEL equatorial domain-like
54849 - GroEL-intermediate domain like | 0.2047 | INHERITED FROM: CD 437 |
64593,64593
64593 - Intermediate filament protein, coiled coil region
64593 - Intermediate filament protein, coiled coil region | 0.2285 | INHERITED FROM: 4-oxoretinoic acid || beta Carotene || Alitretinoin || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
53901,53901
53901 - Thiolase-like
53901 - Thiolase-like | 0.236 | INHERITED FROM: Isotretinoin |
47954,47954
47954 - Cyclin-like
47954 - Cyclin-like | 0.2581 | INHERITED FROM: 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
54001,49758
54001 - Cysteine proteinases
49758 - Calpain large subunit, middle domain (domain III) | 0.2736 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
63411,63411
63411 - LuxS/MPP-like metallohydrolase
63411 - LuxS/MPP-like metallohydrolase | 0.2742 | INHERITED FROM: Isotretinoin |
54928,54928
54928 - RNA-binding domain, RBD
54928 - RNA-binding domain, RBD | 0.2785 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
50129,51735
50129 - GroES-like
51735 - NAD(P)-binding Rossmann-fold domains | 0.3425 | INHERITED FROM: apocarotenal |
47454,57959
47454 - A DNA-binding domain in eukaryotic transcription factors
57959 - Leucine zipper domain | 0.3425 | INHERITED FROM: Cyclohexenes || Vitamin A || Tretinoin || Retinoids |
49758,47473
49758 - Calpain large subunit, middle domain (domain III)
47473 - EF-hand | 0.4633 | INHERITED FROM: Menthol || Cyclohexane Monoterpenes |
54452,48726
54452 - MHC antigen-recognition domain
48726 - Immunoglobulin | 0.4808 | INHERITED FROM: Isotretinoin |
57184,57184
57184 - Growth factor receptor domain
57184 - Growth factor receptor domain | 0.5128 | INHERITED FROM: Cyclohexenes || Chlorogenic Acid || Retinoids |
57440,57440
57440 - Kringle-like
57440 - Kringle-like | 0.5457 | INHERITED FROM: Isotretinoin || Alitretinoin || Cyclohexanecarboxylic Acids |
55550,56112
55550 - SH2 domain
56112 - Protein kinase-like (PK-like) | 0.547 | INHERITED FROM: 4-acetylantroquinonol B || Cyclohexanones |
47090,55486
47090 - PGBD-like
55486 - Metalloproteases ("zincins"), catalytic domain | 0.655 | INHERITED FROM: 3-caffeoyl-4-dihydrocaffeoylquinic acid || Chlorogenic Acid || Cyclohexanecarboxylic Acids |
52490,55307
52490 - Tubulin nucleotide-binding domain-like
55307 - Tubulin C-terminal domain-like | 0.6922 | INHERITED FROM: 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol |
63712,90112
63712 - Nicotinic receptor ligand binding domain-like
90112 - Neurotransmitter-gated ion-channel transmembrane pore | 0.739 | INHERITED FROM: carvone || menthone || Picrotoxin |
| Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
51045,47473
51045 - WW domain
47473 - EF-hand | 0 | Direct |
56491,89811
56491 - A heparin-binding domain
89811 - Amyloid beta a4 protein copper binding domain (domain 2) | 0 | Direct |
53738,55957
53738 - Phosphoglucomutase, first 3 domains
55957 - Phosphoglucomutase, C-terminal domain | 0 | Direct |
53738,53738
53738 - Phosphoglucomutase, first 3 domains
53738 - Phosphoglucomutase, first 3 domains | 0 | Direct |
49695,50370
49695 - gamma-Crystallin-like
50370 - Ricin B-like lectins | 0 | Direct |
47986,52129
47986 - DEATH domain
52129 - Caspase-like | 0 | Direct |
46966,51045
46966 - Spectrin repeat
51045 - WW domain | 0 | Direct |
52540,47917
52540 - P-loop containing nucleoside triphosphate hydrolases
47917 - C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
47986,47986
47986 - DEATH domain
47986 - DEATH domain | 0 | Direct |
49899,63887
49899 - Concanavalin A-like lectins/glucanases
63887 - P-domain of calnexin/calreticulin | 0 | Direct |
69572,69572
69572 - Activating enzymes of the ubiquitin-like proteins
69572 - Activating enzymes of the ubiquitin-like proteins | 0 | Direct |
49899,48726
49899 - Concanavalin A-like lectins/glucanases
48726 - Immunoglobulin | 0 | Direct |
49417,47719
49417 - p53-like transcription factors
47719 - p53 tetramerization domain | 0 | Direct |
57196,57535
57196 - EGF/Laminin
57535 - Complement control module/SCR domain | 0 | Direct |
57924,57924
57924 - Inhibitor of apoptosis (IAP) repeat
57924 - Inhibitor of apoptosis (IAP) repeat | 0 | Direct |
49562,57889
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
57889 - Cysteine-rich domain | 0 | Direct |
51419,50621
51419 - PLP-binding barrel
50621 - Alanine racemase C-terminal domain-like | 0 | Direct |
100920,100934
100920 - Heat shock protein 70kD (HSP70), peptide-binding domain
100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain | 0 | Direct |
53300,49899
53300 - vWA-like
49899 - Concanavalin A-like lectins/glucanases | 0 | Direct |
57586,57586
57586 - TNF receptor-like
57586 - TNF receptor-like | 0.000000002751 | Direct |
52799,52799
52799 - (Phosphotyrosine protein) phosphatases II
52799 - (Phosphotyrosine protein) phosphatases II | 0.0000007479 | Direct |
69179,69179
69179 - Integrin domains
69179 - Integrin domains | 0.0004537 | Direct |
69318,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains | 0.0004537 | Direct |
52833,47616
52833 - Thioredoxin-like
47616 - GST C-terminal domain-like | 0.0005565 | Direct |
53067,100920
53067 - Actin-like ATPase domain
100920 - Heat shock protein 70kD (HSP70), peptide-binding domain | 0.001193 | Inherited |
57850,49599
57850 - RING/U-box
49599 - TRAF domain-like | 0.001741 | Inherited |
46785,144074
46785 - "Winged helix" DNA-binding domain
144074 - E2F-DP heterodimerization region | 0.003114 | Inherited |
57184,57610
57184 - Growth factor receptor domain
57610 - Thyroglobulin type-1 domain | 0.004518 | Inherited |
49785,49785
49785 - Galactose-binding domain-like
49785 - Galactose-binding domain-like | 0.007873 | Inherited |
50729,56112
50729 - PH domain-like
56112 - Protein kinase-like (PK-like) | 0.007873 | Inherited |
46579,64593
46579 - Prefoldin
64593 - Intermediate filament protein, coiled coil region | 0.009865 | Inherited |
56112,56112
56112 - Protein kinase-like (PK-like)
56112 - Protein kinase-like (PK-like) | 0.02292 | Inherited |
57716,48508
57716 - Glucocorticoid receptor-like (DNA-binding domain)
48508 - Nuclear receptor ligand-binding domain | 0.09594 | Inherited |
52518,52922
52518 - Thiamin diphosphate-binding fold (THDP-binding)
52922 - TK C-terminal domain-like | 0.09645 | Inherited |
57196,57196
57196 - EGF/Laminin
57196 - EGF/Laminin | 0.0976 | Inherited |
54849,52029
54849 - GroEL-intermediate domain like
52029 - GroEL apical domain-like | 0.1254 | Inherited |
53067,53067
53067 - Actin-like ATPase domain
53067 - Actin-like ATPase domain | 0.1995 | Inherited |
48592,54849
48592 - GroEL equatorial domain-like
54849 - GroEL-intermediate domain like | 0.2047 | Inherited |
64593,64593
64593 - Intermediate filament protein, coiled coil region
64593 - Intermediate filament protein, coiled coil region | 0.2285 | Inherited |
53901,53901
53901 - Thiolase-like
53901 - Thiolase-like | 0.236 | Inherited |
47954,47954
47954 - Cyclin-like
47954 - Cyclin-like | 0.2581 | Inherited |
54001,49758
54001 - Cysteine proteinases
49758 - Calpain large subunit, middle domain (domain III) | 0.2736 | Inherited |
63411,63411
63411 - LuxS/MPP-like metallohydrolase
63411 - LuxS/MPP-like metallohydrolase | 0.2742 | Inherited |
54928,54928
54928 - RNA-binding domain, RBD
54928 - RNA-binding domain, RBD | 0.2785 | Inherited |
50129,51735
50129 - GroES-like
51735 - NAD(P)-binding Rossmann-fold domains | 0.3425 | Inherited |
47454,57959
47454 - A DNA-binding domain in eukaryotic transcription factors
57959 - Leucine zipper domain | 0.3425 | Inherited |
49758,47473
49758 - Calpain large subunit, middle domain (domain III)
47473 - EF-hand | 0.4633 | Inherited |
54452,48726
54452 - MHC antigen-recognition domain
48726 - Immunoglobulin | 0.4808 | Inherited |
57184,57184
57184 - Growth factor receptor domain
57184 - Growth factor receptor domain | 0.5128 | Inherited |
57440,57440
57440 - Kringle-like
57440 - Kringle-like | 0.5457 | Inherited |
55550,56112
55550 - SH2 domain
56112 - Protein kinase-like (PK-like) | 0.547 | Inherited |
47090,55486
47090 - PGBD-like
55486 - Metalloproteases ("zincins"), catalytic domain | 0.655 | Inherited |
52490,55307
52490 - Tubulin nucleotide-binding domain-like
55307 - Tubulin C-terminal domain-like | 0.6922 | Inherited |
63712,90112
63712 - Nicotinic receptor ligand binding domain-like
90112 - Neurotransmitter-gated ion-channel transmembrane pore | 0.739 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Triple) in N- to C-terminal order( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
57586,57586,57586
57586 - TNF receptor-like
57586 - TNF receptor-like
57586 - TNF receptor-like | 0 | DIRECT |
57184,100895,48726
57184 - Growth factor receptor domain
100895 - Kazal-type serine protease inhibitors
48726 - Immunoglobulin | 0 | DIRECT |
46966,46966,51045
46966 - Spectrin repeat
46966 - Spectrin repeat
51045 - WW domain | 0 | DIRECT |
49562,57889,57889
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
57889 - Cysteine-rich domain
57889 - Cysteine-rich domain | 0 | DIRECT |
49899,48726,49265
49899 - Concanavalin A-like lectins/glucanases
48726 - Immunoglobulin
49265 - Fibronectin type III | 0 | DIRECT |
57196,57535,57535
57196 - EGF/Laminin
57535 - Complement control module/SCR domain
57535 - Complement control module/SCR domain | 0 | DIRECT |
57924,57924,57924
57924 - Inhibitor of apoptosis (IAP) repeat
57924 - Inhibitor of apoptosis (IAP) repeat
57924 - Inhibitor of apoptosis (IAP) repeat | 0 | DIRECT |
53738,53738,53738
53738 - Phosphoglucomutase, first 3 domains
53738 - Phosphoglucomutase, first 3 domains
53738 - Phosphoglucomutase, first 3 domains | 0 | DIRECT |
47986,47986,52129
47986 - DEATH domain
47986 - DEATH domain
52129 - Caspase-like | 0 | DIRECT |
53067,100920,100934
53067 - Actin-like ATPase domain
100920 - Heat shock protein 70kD (HSP70), peptide-binding domain
100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain | 0 | DIRECT |
51045,47473,47473
51045 - WW domain
47473 - EF-hand
47473 - EF-hand | 0 | DIRECT |
46966,51045,47473
46966 - Spectrin repeat
51045 - WW domain
47473 - EF-hand | 0 | DIRECT |
53738,53738,55957
53738 - Phosphoglucomutase, first 3 domains
53738 - Phosphoglucomutase, first 3 domains
55957 - Phosphoglucomutase, C-terminal domain | 0 | DIRECT |
57196,57196,57196
57196 - EGF/Laminin
57196 - EGF/Laminin
57196 - EGF/Laminin | 0.0003543 | DIRECT |
69179,69179,69179
69179 - Integrin domains
69179 - Integrin domains
69179 - Integrin domains | 0.0003739 | DIRECT |
69318,69179,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains
69179 - Integrin domains | 0.0004537 | DIRECT |
53067,53067,100920
53067 - Actin-like ATPase domain
53067 - Actin-like ATPase domain
100920 - Heat shock protein 70kD (HSP70), peptide-binding domain | 0.001193 | INHERITED FROM: aurin || Cyclohexanecarboxylic Acids |
49899,49899,49899
49899 - Concanavalin A-like lectins/glucanases
49899 - Concanavalin A-like lectins/glucanases
49899 - Concanavalin A-like lectins/glucanases | 0.005236 | INHERITED FROM: Vitamin A || Tretinoin |
57850,49599,49599
57850 - RING/U-box
49599 - TRAF domain-like
49599 - TRAF domain-like | 0.01248 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
48592,54849,52029
48592 - GroEL equatorial domain-like
54849 - GroEL-intermediate domain like
52029 - GroEL apical domain-like | 0.2047 | INHERITED FROM: CD 437 |
57196,57196,57184
57196 - EGF/Laminin
57196 - EGF/Laminin
57184 - Growth factor receptor domain | 0.2839 | INHERITED FROM: Cyclohexenes || Retinoids |
46966,46966,46966
46966 - Spectrin repeat
46966 - Spectrin repeat
46966 - Spectrin repeat | 0.3117 | INHERITED FROM: Vitamin A || Tretinoin |
54001,49758,47473
54001 - Cysteine proteinases
49758 - Calpain large subunit, middle domain (domain III)
47473 - EF-hand | 0.3694 | INHERITED FROM: Cyclohexanols || Menthol || Cyclohexane Monoterpenes |
57440,57440,57440
57440 - Kringle-like
57440 - Kringle-like
57440 - Kringle-like | 0.7209 | INHERITED FROM: Isotretinoin |
| Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
57586,57586,57586
57586 - TNF receptor-like
57586 - TNF receptor-like
57586 - TNF receptor-like | 0 | Direct |
57184,100895,48726
57184 - Growth factor receptor domain
100895 - Kazal-type serine protease inhibitors
48726 - Immunoglobulin | 0 | Direct |
46966,46966,51045
46966 - Spectrin repeat
46966 - Spectrin repeat
51045 - WW domain | 0 | Direct |
49562,57889,57889
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
57889 - Cysteine-rich domain
57889 - Cysteine-rich domain | 0 | Direct |
49899,48726,49265
49899 - Concanavalin A-like lectins/glucanases
48726 - Immunoglobulin
49265 - Fibronectin type III | 0 | Direct |
57196,57535,57535
57196 - EGF/Laminin
57535 - Complement control module/SCR domain
57535 - Complement control module/SCR domain | 0 | Direct |
57924,57924,57924
57924 - Inhibitor of apoptosis (IAP) repeat
57924 - Inhibitor of apoptosis (IAP) repeat
57924 - Inhibitor of apoptosis (IAP) repeat | 0 | Direct |
53738,53738,53738
53738 - Phosphoglucomutase, first 3 domains
53738 - Phosphoglucomutase, first 3 domains
53738 - Phosphoglucomutase, first 3 domains | 0 | Direct |
47986,47986,52129
47986 - DEATH domain
47986 - DEATH domain
52129 - Caspase-like | 0 | Direct |
53067,100920,100934
53067 - Actin-like ATPase domain
100920 - Heat shock protein 70kD (HSP70), peptide-binding domain
100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain | 0 | Direct |
51045,47473,47473
51045 - WW domain
47473 - EF-hand
47473 - EF-hand | 0 | Direct |
46966,51045,47473
46966 - Spectrin repeat
51045 - WW domain
47473 - EF-hand | 0 | Direct |
53738,53738,55957
53738 - Phosphoglucomutase, first 3 domains
53738 - Phosphoglucomutase, first 3 domains
55957 - Phosphoglucomutase, C-terminal domain | 0 | Direct |
57196,57196,57196
57196 - EGF/Laminin
57196 - EGF/Laminin
57196 - EGF/Laminin | 0.0003543 | Direct |
69179,69179,69179
69179 - Integrin domains
69179 - Integrin domains
69179 - Integrin domains | 0.0003739 | Direct |
69318,69179,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains
69179 - Integrin domains | 0.0004537 | Direct |
53067,53067,100920
53067 - Actin-like ATPase domain
53067 - Actin-like ATPase domain
100920 - Heat shock protein 70kD (HSP70), peptide-binding domain | 0.001193 | Inherited |
49899,49899,49899
49899 - Concanavalin A-like lectins/glucanases
49899 - Concanavalin A-like lectins/glucanases
49899 - Concanavalin A-like lectins/glucanases | 0.005236 | Inherited |
57850,49599,49599
57850 - RING/U-box
49599 - TRAF domain-like
49599 - TRAF domain-like | 0.01248 | Inherited |
48592,54849,52029
48592 - GroEL equatorial domain-like
54849 - GroEL-intermediate domain like
52029 - GroEL apical domain-like | 0.2047 | Inherited |
57196,57196,57184
57196 - EGF/Laminin
57196 - EGF/Laminin
57184 - Growth factor receptor domain | 0.2839 | Inherited |
46966,46966,46966
46966 - Spectrin repeat
46966 - Spectrin repeat
46966 - Spectrin repeat | 0.3117 | Inherited |
54001,49758,47473
54001 - Cysteine proteinases
49758 - Calpain large subunit, middle domain (domain III)
47473 - EF-hand | 0.3694 | Inherited |
57440,57440,57440
57440 - Kringle-like
57440 - Kringle-like
57440 - Kringle-like | 0.7209 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Plot distribution on species Tree Of Life (sTOL) for Superfamily and/or Family domains annotated by this CC term
 |
Plot tree as:
| |
Download Newick format tree:
|
( show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domain
architecture data for all genomes in SUPERFAMILY. The PAUP
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
Plot distribution on species Tree Of Life (sTOL) for single supra-domains annotated by this CC term
|
Plot tree as:
| |
Download Newick format tree:
| |
Browsing in TREE OF LIFE:
|
( show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domains and supradomains
for all genomes in SUPERFAMILY. The RAxML
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
|
|
> BO Hierarchy > Cyclohexanes
